full wwpdb em map/model validation report o i · full wwpdb em map/model validation report o i sep...
TRANSCRIPT
Full wwPDB EM Validation Report i○
Dec 15, 2020 – 02:58 PM EST
PDB ID : 6NB7EMDB ID : EMD-0404
Title : SARS-CoV complex with human neutralizing S230 antibody Fab fragment(state 2)
Authors : Walls, A.C.; Xiong, X.; Park, Y.J.; Tortorici, M.A.; Snijder, S.; Quispe, J.;Cameroni, E.; Gopal, R.; Mian, D.; Lanzavecchia, A.; Zambon, M.; Rey,F.A.; Corti, D.; Veesler, D.; Seattle Structural Genomics Center for InfectiousDisease (SSGCID)
Deposited on : 2018-12-06Resolution : 4.50 Å(reported)
This is a Full wwPDB EM Validation Report for a publicly released PDB entry.
We welcome your comments at [email protected] user guide is available at
https://www.wwpdb.org/validation/2017/EMValidationReportHelpwith specific help available everywhere you see the i○ symbol.
The following versions of software and data (see references i○) were used in the production of this report:
EMDB validation analysis : 0.0.0.dev61Mogul : 1.8.5 (274361), CSD as541be (2020)
MolProbity : 4.02b-467Percentile statistics : 20191225.v01 (using entries in the PDB archive December 25th 2019)
Ideal geometry (proteins) : Engh & Huber (2001)Ideal geometry (DNA, RNA) : Parkinson et al. (1996)
Validation Pipeline (wwPDB-VP) : 2.15.1
Page 2 Full wwPDB EM Validation Report EMD-0404, 6NB7
1 Overall quality at a glance i○
The following experimental techniques were used to determine the structure:ELECTRON MICROSCOPY
The reported resolution of this entry is 4.50 Å.
Percentile scores (ranging between 0-100) for global validation metrics of the entry are shown inthe following graphic. The table shows the number of entries on which the scores are based.
Metric Whole archive(#Entries)
EM structures(#Entries)
Ramachandran outliers 154571 4023Sidechain outliers 154315 3826
The table below summarises the geometric issues observed across the polymeric chains and their fitto the map. The red, orange, yellow and green segments of the bar indicate the fraction of residuesthat contain outliers for >=3, 2, 1 and 0 types of geometric quality criteria respectively. A greysegment represents the fraction of residues that are not modelled. The numeric value for eachfraction is indicated below the corresponding segment, with a dot representing fractions <=5%The upper red bar (where present) indicates the fraction of residues that have poor fit to the EMmap (all-atom inclusion < 40%). The numeric value is given above the bar.
Mol Chain Length Quality of chain
1 A 1263
1 B 1263
1 C 1263
2 D 127
2 G 127
2 H 127
3 E 112
3 I 112
3 L 112Continued on next page...
Page 3 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Length Quality of chain
4 F 3
4 J 3
4 K 3
4 M 3
4 N 3
4 O 3
4 Q 3
4 V 3
4 X 3
4 Y 3
4 Z 3
4 a 3
4 c 3
4 e 3
4 h 3
4 j 3
4 l 3
4 m 3
4 n 3
4 r 3
4 t 3
5 P 5
5 R 5
5 S 5
5 U 5Continued on next page...
Page 4 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Length Quality of chain
5 d 5
5 q 5
6 T 4
6 s 4
7 W 2
7 b 2
7 i 2
7 k 2
7 o 2
7 p 2
8 f 4
8 g 4
Page 5 Full wwPDB EM Validation Report EMD-0404, 6NB7
2 Entry composition i○
There are 9 unique types of molecules in this entry. The entry contains 24718 atoms, of which 0are hydrogens and 0 are deuteriums.
In the tables below, the AltConf column contains the number of residues with at least one atomin alternate conformation and the Trace column contains the number of residues modelled with atmost 2 atoms.
• Molecule 1 is a protein called Spike glycoprotein.
Mol Chain Residues Atoms AltConf Trace
1 A 1049 Total C N O S6609 4147 1200 1223 39 0 0
1 B 1032 Total C N O S6428 4027 1171 1191 39 0 0
1 C 1048 Total C N O S6394 4018 1167 1172 37 0 0
There are 261 discrepancies between the modelled and reference sequences:
Chain Residue Modelled Actual Comment ReferenceA -18 MET - initiating methionine UNP P59594A -17 GLY - expression tag UNP P59594A -16 ILE - expression tag UNP P59594A -15 LEU - expression tag UNP P59594A -14 PRO - expression tag UNP P59594A -13 SER - expression tag UNP P59594A -12 PRO - expression tag UNP P59594A -11 GLY - expression tag UNP P59594A -10 MET - expression tag UNP P59594A -9 PRO - expression tag UNP P59594A -8 ALA - expression tag UNP P59594A -7 LEU - expression tag UNP P59594A -6 LEU - expression tag UNP P59594A -5 SER - expression tag UNP P59594A -4 LEU - expression tag UNP P59594A -3 VAL - expression tag UNP P59594A -2 SER - expression tag UNP P59594A -1 LEU - expression tag UNP P59594A 0 LEU - expression tag UNP P59594A 1 SER - expression tag UNP P59594A 2 VAL - expression tag UNP P59594A 3 LEU - expression tag UNP P59594A 4 LEU - expression tag UNP P59594A 5 MET - expression tag UNP P59594
Continued on next page...
Page 6 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Chain Residue Modelled Actual Comment Reference
A 6 GLY - expression tag UNP P59594A 7 CYS - expression tag UNP P59594A 8 VAL - expression tag UNP P59594A 9 ALA - expression tag UNP P59594A 10 GLU - expression tag UNP P59594A 11 THR - expression tag UNP P59594A 12 GLY - expression tag UNP P59594A 13 THR - expression tag UNP P59594A 77 ASP GLY conflict UNP P59594A 244 THR ILE conflict UNP P59594A 968 PRO LYS conflict UNP P59594A 969 PRO VAL conflict UNP P59594A 1194 GLY - expression tag UNP P59594A 1195 SER - expression tag UNP P59594A 1196 GLY - expression tag UNP P59594A 1197 ARG - expression tag UNP P59594A 1198 GLU - expression tag UNP P59594A 1199 ASN - expression tag UNP P59594A 1200 LEU - expression tag UNP P59594A 1201 TYR - expression tag UNP P59594A 1202 PHE - expression tag UNP P59594A 1203 GLN - expression tag UNP P59594A 1204 GLY - expression tag UNP P59594A 1205 GLY - expression tag UNP P59594A 1206 GLY - expression tag UNP P59594A 1207 GLY - expression tag UNP P59594A 1208 SER - expression tag UNP P59594A 1209 GLY - expression tag UNP P59594A 1210 TYR - expression tag UNP P59594A 1211 ILE - expression tag UNP P59594A 1212 PRO - expression tag UNP P59594A 1213 GLU - expression tag UNP P59594A 1214 ALA - expression tag UNP P59594A 1215 PRO - expression tag UNP P59594A 1216 ARG - expression tag UNP P59594A 1217 ASP - expression tag UNP P59594A 1218 GLY - expression tag UNP P59594A 1219 GLN - expression tag UNP P59594A 1220 ALA - expression tag UNP P59594A 1221 TYR - expression tag UNP P59594A 1222 VAL - expression tag UNP P59594A 1223 ARG - expression tag UNP P59594
Continued on next page...
Page 7 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Chain Residue Modelled Actual Comment Reference
A 1224 LYS - expression tag UNP P59594A 1225 ASP - expression tag UNP P59594A 1226 GLY - expression tag UNP P59594A 1227 GLU - expression tag UNP P59594A 1228 TRP - expression tag UNP P59594A 1229 VAL - expression tag UNP P59594A 1230 LEU - expression tag UNP P59594A 1231 LEU - expression tag UNP P59594A 1232 SER - expression tag UNP P59594A 1233 THR - expression tag UNP P59594A 1234 PHE - expression tag UNP P59594A 1235 LEU - expression tag UNP P59594A 1236 GLY - expression tag UNP P59594A 1237 HIS - expression tag UNP P59594A 1238 HIS - expression tag UNP P59594A 1239 HIS - expression tag UNP P59594A 1240 HIS - expression tag UNP P59594A 1241 HIS - expression tag UNP P59594A 1242 HIS - expression tag UNP P59594A 1243 HIS - expression tag UNP P59594A 1244 HIS - expression tag UNP P59594B -18 MET - initiating methionine UNP P59594B -17 GLY - expression tag UNP P59594B -16 ILE - expression tag UNP P59594B -15 LEU - expression tag UNP P59594B -14 PRO - expression tag UNP P59594B -13 SER - expression tag UNP P59594B -12 PRO - expression tag UNP P59594B -11 GLY - expression tag UNP P59594B -10 MET - expression tag UNP P59594B -9 PRO - expression tag UNP P59594B -8 ALA - expression tag UNP P59594B -7 LEU - expression tag UNP P59594B -6 LEU - expression tag UNP P59594B -5 SER - expression tag UNP P59594B -4 LEU - expression tag UNP P59594B -3 VAL - expression tag UNP P59594B -2 SER - expression tag UNP P59594B -1 LEU - expression tag UNP P59594B 0 LEU - expression tag UNP P59594B 1 SER - expression tag UNP P59594B 2 VAL - expression tag UNP P59594
Continued on next page...
Page 8 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Chain Residue Modelled Actual Comment Reference
B 3 LEU - expression tag UNP P59594B 4 LEU - expression tag UNP P59594B 5 MET - expression tag UNP P59594B 6 GLY - expression tag UNP P59594B 7 CYS - expression tag UNP P59594B 8 VAL - expression tag UNP P59594B 9 ALA - expression tag UNP P59594B 10 GLU - expression tag UNP P59594B 11 THR - expression tag UNP P59594B 12 GLY - expression tag UNP P59594B 13 THR - expression tag UNP P59594B 77 ASP GLY conflict UNP P59594B 244 THR ILE conflict UNP P59594B 968 PRO LYS conflict UNP P59594B 969 PRO VAL conflict UNP P59594B 1194 GLY - expression tag UNP P59594B 1195 SER - expression tag UNP P59594B 1196 GLY - expression tag UNP P59594B 1197 ARG - expression tag UNP P59594B 1198 GLU - expression tag UNP P59594B 1199 ASN - expression tag UNP P59594B 1200 LEU - expression tag UNP P59594B 1201 TYR - expression tag UNP P59594B 1202 PHE - expression tag UNP P59594B 1203 GLN - expression tag UNP P59594B 1204 GLY - expression tag UNP P59594B 1205 GLY - expression tag UNP P59594B 1206 GLY - expression tag UNP P59594B 1207 GLY - expression tag UNP P59594B 1208 SER - expression tag UNP P59594B 1209 GLY - expression tag UNP P59594B 1210 TYR - expression tag UNP P59594B 1211 ILE - expression tag UNP P59594B 1212 PRO - expression tag UNP P59594B 1213 GLU - expression tag UNP P59594B 1214 ALA - expression tag UNP P59594B 1215 PRO - expression tag UNP P59594B 1216 ARG - expression tag UNP P59594B 1217 ASP - expression tag UNP P59594B 1218 GLY - expression tag UNP P59594B 1219 GLN - expression tag UNP P59594B 1220 ALA - expression tag UNP P59594
Continued on next page...
Page 9 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Chain Residue Modelled Actual Comment Reference
B 1221 TYR - expression tag UNP P59594B 1222 VAL - expression tag UNP P59594B 1223 ARG - expression tag UNP P59594B 1224 LYS - expression tag UNP P59594B 1225 ASP - expression tag UNP P59594B 1226 GLY - expression tag UNP P59594B 1227 GLU - expression tag UNP P59594B 1228 TRP - expression tag UNP P59594B 1229 VAL - expression tag UNP P59594B 1230 LEU - expression tag UNP P59594B 1231 LEU - expression tag UNP P59594B 1232 SER - expression tag UNP P59594B 1233 THR - expression tag UNP P59594B 1234 PHE - expression tag UNP P59594B 1235 LEU - expression tag UNP P59594B 1236 GLY - expression tag UNP P59594B 1237 HIS - expression tag UNP P59594B 1238 HIS - expression tag UNP P59594B 1239 HIS - expression tag UNP P59594B 1240 HIS - expression tag UNP P59594B 1241 HIS - expression tag UNP P59594B 1242 HIS - expression tag UNP P59594B 1243 HIS - expression tag UNP P59594B 1244 HIS - expression tag UNP P59594C -18 MET - initiating methionine UNP P59594C -17 GLY - expression tag UNP P59594C -16 ILE - expression tag UNP P59594C -15 LEU - expression tag UNP P59594C -14 PRO - expression tag UNP P59594C -13 SER - expression tag UNP P59594C -12 PRO - expression tag UNP P59594C -11 GLY - expression tag UNP P59594C -10 MET - expression tag UNP P59594C -9 PRO - expression tag UNP P59594C -8 ALA - expression tag UNP P59594C -7 LEU - expression tag UNP P59594C -6 LEU - expression tag UNP P59594C -5 SER - expression tag UNP P59594C -4 LEU - expression tag UNP P59594C -3 VAL - expression tag UNP P59594C -2 SER - expression tag UNP P59594C -1 LEU - expression tag UNP P59594
Continued on next page...
Page 10 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Chain Residue Modelled Actual Comment Reference
C 0 LEU - expression tag UNP P59594C 1 SER - expression tag UNP P59594C 2 VAL - expression tag UNP P59594C 3 LEU - expression tag UNP P59594C 4 LEU - expression tag UNP P59594C 5 MET - expression tag UNP P59594C 6 GLY - expression tag UNP P59594C 7 CYS - expression tag UNP P59594C 8 VAL - expression tag UNP P59594C 9 ALA - expression tag UNP P59594C 10 GLU - expression tag UNP P59594C 11 THR - expression tag UNP P59594C 12 GLY - expression tag UNP P59594C 13 THR - expression tag UNP P59594C 77 ASP GLY conflict UNP P59594C 244 THR ILE conflict UNP P59594C 968 PRO LYS conflict UNP P59594C 969 PRO VAL conflict UNP P59594C 1194 GLY - expression tag UNP P59594C 1195 SER - expression tag UNP P59594C 1196 GLY - expression tag UNP P59594C 1197 ARG - expression tag UNP P59594C 1198 GLU - expression tag UNP P59594C 1199 ASN - expression tag UNP P59594C 1200 LEU - expression tag UNP P59594C 1201 TYR - expression tag UNP P59594C 1202 PHE - expression tag UNP P59594C 1203 GLN - expression tag UNP P59594C 1204 GLY - expression tag UNP P59594C 1205 GLY - expression tag UNP P59594C 1206 GLY - expression tag UNP P59594C 1207 GLY - expression tag UNP P59594C 1208 SER - expression tag UNP P59594C 1209 GLY - expression tag UNP P59594C 1210 TYR - expression tag UNP P59594C 1211 ILE - expression tag UNP P59594C 1212 PRO - expression tag UNP P59594C 1213 GLU - expression tag UNP P59594C 1214 ALA - expression tag UNP P59594C 1215 PRO - expression tag UNP P59594C 1216 ARG - expression tag UNP P59594C 1217 ASP - expression tag UNP P59594
Continued on next page...
Page 11 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Chain Residue Modelled Actual Comment Reference
C 1218 GLY - expression tag UNP P59594C 1219 GLN - expression tag UNP P59594C 1220 ALA - expression tag UNP P59594C 1221 TYR - expression tag UNP P59594C 1222 VAL - expression tag UNP P59594C 1223 ARG - expression tag UNP P59594C 1224 LYS - expression tag UNP P59594C 1225 ASP - expression tag UNP P59594C 1226 GLY - expression tag UNP P59594C 1227 GLU - expression tag UNP P59594C 1228 TRP - expression tag UNP P59594C 1229 VAL - expression tag UNP P59594C 1230 LEU - expression tag UNP P59594C 1231 LEU - expression tag UNP P59594C 1232 SER - expression tag UNP P59594C 1233 THR - expression tag UNP P59594C 1234 PHE - expression tag UNP P59594C 1235 LEU - expression tag UNP P59594C 1236 GLY - expression tag UNP P59594C 1237 HIS - expression tag UNP P59594C 1238 HIS - expression tag UNP P59594C 1239 HIS - expression tag UNP P59594C 1240 HIS - expression tag UNP P59594C 1241 HIS - expression tag UNP P59594C 1242 HIS - expression tag UNP P59594C 1243 HIS - expression tag UNP P59594C 1244 HIS - expression tag UNP P59594
• Molecule 2 is a protein called S230 heavy chain.
Mol Chain Residues Atoms AltConf Trace
2 D 123 Total C N O S613 365 123 123 2 0 0
2 G 123 Total C N O S613 365 123 123 2 0 0
2 H 123 Total C N O S613 365 123 123 2 0 0
• Molecule 3 is a protein called S230 light chain.
Page 12 Full wwPDB EM Validation Report EMD-0404, 6NB7
Mol Chain Residues Atoms AltConf Trace
3 E 110 Total C N O S557 335 110 110 2 0 0
3 I 110 Total C N O S557 335 110 110 2 0 0
3 L 110 Total C N O S557 335 110 110 2 0 0
• Molecule 4 is an oligosaccharide called beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose.
Mol Chain Residues Atoms AltConf Trace
4 F 3 Total C N O39 22 2 15 0 0
4 J 3 Total C N O39 22 2 15 0 0
4 K 3 Total C N O39 22 2 15 0 0
4 M 3 Total C N O39 22 2 15 0 0
4 N 3 Total C N O39 22 2 15 0 0
4 O 3 Total C N O39 22 2 15 0 0
4 Q 3 Total C N O39 22 2 15 0 0
4 V 3 Total C N O39 22 2 15 0 0
4 X 3 Total C N O39 22 2 15 0 0
4 Y 3 Total C N O39 22 2 15 0 0
4 Z 3 Total C N O39 22 2 15 0 0
4 a 3 Total C N O39 22 2 15 0 0
4 c 3 Total C N O39 22 2 15 0 0
4 e 3 Total C N O39 22 2 15 0 0
Continued on next page...
Page 13 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Residues Atoms AltConf Trace
4 h 3 Total C N O39 22 2 15 0 0
4 j 3 Total C N O39 22 2 15 0 0
4 l 3 Total C N O39 22 2 15 0 0
4 m 3 Total C N O39 22 2 15 0 0
4 n 3 Total C N O39 22 2 15 0 0
4 r 3 Total C N O39 22 2 15 0 0
4 t 3 Total C N O39 22 2 15 0 0
• Molecule 5 is an oligosaccharide called alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose.
Mol Chain Residues Atoms AltConf Trace
5 P 5 Total C N O61 34 2 25 0 0
5 R 5 Total C N O61 34 2 25 0 0
5 S 5 Total C N O61 34 2 25 0 0
5 U 5 Total C N O61 34 2 25 0 0
5 d 5 Total C N O61 34 2 25 0 0
5 q 5 Total C N O61 34 2 25 0 0
• Molecule 6 is an oligosaccharide called alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose.
Page 14 Full wwPDB EM Validation Report EMD-0404, 6NB7
Mol Chain Residues Atoms AltConf Trace
6 T 4 Total C N O50 28 2 20 0 0
6 s 4 Total C N O50 28 2 20 0 0
• Molecule 7 is an oligosaccharide called 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose.
Mol Chain Residues Atoms AltConf Trace
7 W 2 Total C N O28 16 2 10 0 0
7 b 2 Total C N O28 16 2 10 0 0
7 i 2 Total C N O28 16 2 10 0 0
7 k 2 Total C N O28 16 2 10 0 0
7 o 2 Total C N O28 16 2 10 0 0
7 p 2 Total C N O28 16 2 10 0 0
• Molecule 8 is an oligosaccharide called alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose.
Mol Chain Residues Atoms AltConf Trace
8 f 4 Total C N O50 28 2 20 0 0
Continued on next page...
Page 15 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Residues Atoms AltConf Trace
8 g 4 Total C N O50 28 2 20 0 0
• Molecule 9 is 2-acetamido-2-deoxy-beta-D-glucopyranose (three-letter code: NAG) (formula:C8H15NO6).
Mol Chain Residues Atoms AltConf
9 A 1 Total C N O84 48 6 30 0
9 A 1 Total C N O84 48 6 30 0
9 A 1 Total C N O84 48 6 30 0
9 A 1 Total C N O84 48 6 30 0
9 A 1 Total C N O84 48 6 30 0
9 A 1 Total C N O84 48 6 30 0
9 B 1 Total C N O84 48 6 30 0
9 B 1 Total C N O84 48 6 30 0
9 B 1 Total C N O84 48 6 30 0
9 B 1 Total C N O84 48 6 30 0
Continued on next page...
Page 16 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Residues Atoms AltConf
9 B 1 Total C N O84 48 6 30 0
9 B 1 Total C N O84 48 6 30 0
9 C 1 Total C N O56 32 4 20 0
9 C 1 Total C N O56 32 4 20 0
9 C 1 Total C N O56 32 4 20 0
9 C 1 Total C N O56 32 4 20 0
Page 17 Full wwPDB EM Validation Report EMD-0404, 6NB7
3 Residue-property plots i○
These plots are drawn for all protein, RNA, DNA and oligosaccharide chains in the entry. Thefirst graphic for a chain summarises the proportions of the various outlier classes displayed in thesecond graphic. The second graphic shows the sequence view annotated by issues in geometry andatom inclusion in map density. Residues are color-coded according to the number of geometricquality criteria for which they contain at least one outlier: green = 0, yellow = 1, orange = 2and red = 3 or more. A red diamond above a residue indicates a poor fit to the EM map forthis residue (all-atom inclusion < 40%). Stretches of 2 or more consecutive residues without anyoutlier are shown as a green connector. Residues present in the sample, but not in the model, areshown in grey.
• Molecule 1: Spike glycoprotein
Chain A:
MET
GLY
ILE
LEU
PRO
SER
PRO
GLY
MET
PRO
ALA
LEU
LEU
SER
LEU
VAL
SER
LEU
LEU
SER
VAL
LEU
LEU
MET
GLY
CYS
VAL
ALA
GLU
THR
GLY
THR
SER
ASP
LEU
ASP
R18
T21
�PH
EAS
PAS
PVA
LGL
NAL
APR
OAS
NTY
RT3
1
N65
P136
�F1
37�
F138
A139
VAL
SER
LYS
PRO
MET
GLY
THR
GLN
T148
�
N158
S169
LEU
ASP
VAL
SER
GLU
LYS
SER
GLY
ASN
F179
V205
�
N227
A233
�
F238
SER
PRO
ALA
GLN
ASP
THR
TRP
GLY
THR
SER
ALA
A250
I319
A331
�T3
32�
N357
S432
�T4
33�
N457
�
P466
�
P470
�A4
71�
L472
�
T485
�T4
86�
T487
�G4
88�
I489
�
L503
�L5
04�
N505
�A5
06�
P507
�
S516
�
D600
V663
SER
LEU
LEU
ARG
SER
THR
SER
Q671
V808
THR
LEU
ALA
ASP
ALA
GLY
PHE
MET
LYS
Q818
L823
GLY
ASP
ILE
ASN
ALA
ARG
ASP
LEU
I832
P969
N108
0G1
081
L112
7AS
PSE
RPH
ELY
SGL
UGL
ULE
U
ASP
LYS
TYR
PHE
LYS
ASN
HIS
THR
SER
PRO
ASP
VAL
ASP
LEU
GLY
ASP
ILE
SER
GLY
ILE
ASN
ALA
SER
VAL
VAL
ASN
ILE
GLN
LYS
GLU
ILE
ASP
ARG
LEU
ASN
GLU
VAL
ALA
LYS
ASN
LEU
ASN
GLU
SER
LEU
ILE
ASP
LEU
GLN
GLU
LEU
GLY
LYS
TYR
GLU
GLN
TYR
ILE
LYS
GLY
SER
GLY
ARG
GLU
ASN
LEU
TYR
PHE
GLN
GLY
GLY
GLY
GLY
SER
GLY
TYR
ILE
PRO
GLU
ALA
PRO
ARG
ASP
GLY
GLN
ALA
TYR
VAL
ARG
LYS
ASP
GLY
GLU
TRP
VAL
LEU
LEU
SER
THR
PHE
LEU
GLY
HIS
HIS
HIS
HIS
HIS
HIS
HIS
HIS
• Molecule 1: Spike glycoprotein
Chain B:
MET
GLY
ILE
LEU
PRO
SER
PRO
GLY
MET
PRO
ALA
LEU
LEU
SER
LEU
VAL
SER
LEU
LEU
SER
VAL
LEU
LEU
MET
GLY
CYS
VAL
ALA
GLU
THR
GLY
THR
SER
ASP
LEU
ASP
R18
T21
�PH
EAS
PAS
PVA
LGL
NAL
APR
ON2
9Y3
0�
G39
�
D85
�
N109
K110
�
N119
F137
PHE
ALA
VAL
SER
LYS
PRO
MET
GLY
THR
GLN
THR
H149
S169
LEU
ASP
VAL
SER
GLU
LYS
SER
GLY
ASN
F179
D191
�G1
92�
T236
�AL
APH
ESE
RPR
OAL
AGL
NAS
PTH
RTR
PGL
YTH
RSE
RAL
AA2
50�
N269
T332
�K3
33�
D414
�D4
15�
F416
�M4
17G4
18
S432
�T4
33�
H445
�
I455
�
S456
�N4
57�
F460
�S4
61�
G464
�K4
65�
P466
�C4
67�
T468
�P4
69�
P470
�A4
71�
F483
TYR
THR
THR
THR
GLY
ILE
GLY
TYR
Q492
E502
LEU
LEU
ASN
ALA
PRO
ALA
T509
V663
SER
LEU
LEU
ARG
SER
THR
SER
Q671
F784
V808
THR
LEU
ALA
ASP
ALA
GLY
PHE
MET
LYS
Q818
L823
Page 18 Full wwPDB EM Validation Report EMD-0404, 6NB7
GLY
ASP
ILE
ASN
ALA
ARG
ASP
LEU
I832
S957
�
S964
�
N108
0G1
081
L112
7AS
PSE
RPH
ELY
SGL
UGL
ULE
UAS
PLY
STY
RPH
ELY
SAS
NHI
STH
RSE
RPR
OAS
PVA
LAS
PLE
UGL
YAS
PIL
ESE
RGL
YIL
EAS
NAL
ASE
RVA
LVA
LAS
NIL
EGL
NLY
SGL
UIL
EAS
PAR
GLE
UAS
N
GLU
VAL
ALA
LYS
ASN
LEU
ASN
GLU
SER
LEU
ILE
ASP
LEU
GLN
GLU
LEU
GLY
LYS
TYR
GLU
GLN
TYR
ILE
LYS
GLY
SER
GLY
ARG
GLU
ASN
LEU
TYR
PHE
GLN
GLY
GLY
GLY
GLY
SER
GLY
TYR
ILE
PRO
GLU
ALA
PRO
ARG
ASP
GLY
GLN
ALA
TYR
VAL
ARG
LYS
ASP
GLY
GLU
TRP
VAL
LEU
LEU
SER
THR
PHE
LEU
GLY
HIS
HIS
HIS
HIS
HIS
HIS
HIS
HIS
• Molecule 1: Spike glycoprotein
Chain C:
MET
GLY
ILE
LEU
PRO
SER
PRO
GLY
MET
PRO
ALA
LEU
LEU
SER
LEU
VAL
SER
LEU
LEU
SER
VAL
LEU
LEU
MET
GLY
CYS
VAL
ALA
GLU
THR
GLY
THR
SER
ASP
LEU
ASP
R18
�
T21
PHE
ASP
ASP
VAL
GLN
ALA
PRO
ASN
Y30
�
N65
N119
F137
PHE
ALA
VAL
SER
LYS
PRO
MET
GLY
THR
GLN
THR
H149
F168
SER
LEU
ASP
VAL
SER
GLU
LYS
SER
GLY
ASN
F179
F238
SER
PRO
ALA
GLN
ASP
THR
TRP
GLY
T247
N318
S432
�T4
33�
Y442
�
N457
�V4
58�
S461
�
G464
�
C467
T468
�P4
69P4
70�
A471
�L4
72�
T485
�T4
86�
T487
�G4
88�
L503
�L5
04�
N505
�
A506
�P5
07�
V663
SER
LEU
LEU
ARG
SER
THR
SER
Q671
N691
V808
THR
LEU
ALA
ASP
ALA
GLY
PHE
MET
LYS
GLN
Y819
L823
GLY
ASP
ILE
ASN
ALA
ARG
ASP
LEU
I832
S957
�
P969
L112
7AS
PSE
RPH
ELY
SGL
UGL
ULE
UAS
PLY
STY
RPH
ELY
SAS
NHI
STH
RSE
R
PRO
ASP
VAL
ASP
LEU
GLY
ASP
ILE
SER
GLY
ILE
ASN
ALA
SER
VAL
VAL
ASN
ILE
GLN
LYS
GLU
ILE
ASP
ARG
LEU
ASN
GLU
VAL
ALA
LYS
ASN
LEU
ASN
GLU
SER
LEU
ILE
ASP
LEU
GLN
GLU
LEU
GLY
LYS
TYR
GLU
GLN
TYR
ILE
LYS
GLY
SER
GLY
ARG
GLU
ASN
LEU
TYR
PHE
GLN
GLY
GLY
GLY
GLY
SER
GLY
TYR
ILE
PRO
GLU
ALA
PRO
ARG
ASP
GLY
GLN
ALA
TYR
VAL
ARG
LYS
ASP
GLY
GLU
TRP
VAL
LEU
LEU
SER
THR
PHE
LEU
GLY
HIS
HIS
HIS
HIS
HIS
HIS
HIS
HIS
• Molecule 2: S230 heavy chain
Chain D:
GLN
A2 S7�
G8�
G9�
A10
L11
�V1
2�
Q13
�P1
4�
G15
�R1
6�
S17
�
S25
�G2
6�
A40
�P4
1�
A42
�T4
3�
G44
�
Y60
�A6
1�
D62
�S6
3�
V64
�K6
5�
G66
�
S75
�
D84
�S8
5�
L86
�R8
7�
G88
�E8
9�
D90
�
M114
�
A124
VAL
SER
SER
• Molecule 2: S230 heavy chain
Chain G:
GLN
A2 S7�
G8�
G9�
A10
�L1
1�
V12
�Q1
3�
P14
�G1
5�
R16
�S1
7�
S25
�G2
6�
F27
�
P41
�A4
2�
S63
�V6
4�
D74
�S7
5�
K76
�
D84
�S8
5�
G88
�E8
9�
R100
�D1
01�
T121
�T1
22�
V123
A124
�VA
LSE
RSE
R
• Molecule 2: S230 heavy chain
Chain H:
Page 19 Full wwPDB EM Validation Report EMD-0404, 6NB7
GLN
A2�
Q3�
G8�
G9�
A10
�L1
1�
V12
�Q1
3�
P14
�G1
5�
S25
�G2
6�
F27
�T2
8�
P41
�A4
2�
D62
�
D74
�S7
5�
K76
�
G88
�
Q119
�
A124
VAL
SER
SER
• Molecule 3: S230 light chain
Chain E:
ASP
VAL
V3�
L4�
T5�
Q6�
S7�
P8�
L9�
S10
�L1
1�
P12
�V1
3�
T14
�L1
5�
G16
�Q1
7�
P18
�A1
9�
S20
�I2
1S2
2�
C23
R24
�S2
5�
S26
�Q2
7�
S28
�L2
9�
V30
�
D33
�G3
4�
P45
�G4
6�
D65
�
S70
�G7
1�
S72
�G7
3�
T74
�D7
5�
S81
�R8
2�
V83
�E8
4�
Q105
�
E110
�I1
11�
K112
�
• Molecule 3: S230 light chain
Chain I:
ASP
VAL
V3 S7�
P8�
L9�
S10
�L1
1P1
2�
V13
�T1
4�
L15
�G1
6�
Q17
�P1
8�
S32
�D3
3�
G34
�D3
5�
G46
�Q4
7�
S57
�N5
8�
R59
�D6
0�
S61
�G6
2�
V63
�P6
4�
D65
�R6
6�
F67
�S6
8�
G69
�S7
0�
G71
�S7
2�
G73
�T7
4D7
5�
S81
�R8
2�
V83
�E8
4�
A85
�E8
6�
G89
�V9
0Y9
1�
T107
�
E110
�I1
11�
K112
�
• Molecule 3: S230 light chain
Chain L:
ASP
VAL
V3 S7�
P8�
L9 S10
�L1
1�
P12
�V1
3�
T14
�L1
5�
G16
�Q1
7�
P18
�A1
9�
D33
�G3
4�
D35
�
P45
�G4
6�
R59
�D6
0�
S61
�G6
2�
V63
�P6
4�
D65
�R6
6�
F67
S68
�G6
9�
S70
�G7
1�
S72
�G7
3�
S81
�R8
2�
V83
�E8
4�
A85
�E8
6�
D87
�V8
8�
E110
�I1
11�
K112
�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain F:
NAG1
NAG2
�BM
A3�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain J:
NAG1
NAG2
BMA3
�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Page 20 Full wwPDB EM Validation Report EMD-0404, 6NB7
Chain K:NA
G1NA
G2BM
A3
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain M:
NAG1
NAG2
BMA3
�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain N:
NAG1
NAG2
�BM
A3�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain O:
NAG1
NAG2
BMA3
�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain Q:
NAG1
NAG2
BMA3
�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain V:
NAG1
�NA
G2�
BMA3
�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Page 21 Full wwPDB EM Validation Report EMD-0404, 6NB7
Chain X:NA
G1NA
G2BM
A3
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain Y:
NAG1
NAG2
BMA3
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain Z:
NAG1
NAG2
�BM
A3�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain a:
NAG1
NAG2
�BM
A3
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain c:
NAG1
NAG2
BMA3
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain e:
NAG1
NAG2
�BM
A3�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain h:
Page 22 Full wwPDB EM Validation Report EMD-0404, 6NB7
NAG1
NAG2
�BM
A3�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain j:
NAG1
�NA
G2�
BMA3
�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain l:
NAG1
NAG2
BMA3
�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain m:
NAG1
NAG2
BMA3
�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain n:
NAG1
NAG2
BMA3
�
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain r:
NAG1
NAG2
BMA3
• Molecule 4: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain t:
Page 23 Full wwPDB EM Validation Report EMD-0404, 6NB7
NAG1
NAG2
�BM
A3�
• Molecule 5: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain P:
NAG1
NAG2
BMA3
�MA
N4�
MAN5
�
• Molecule 5: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain R:
NAG1
NAG2
BMA3
MAN4
�MA
N5�
• Molecule 5: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain S:
NAG1
NAG2
�BM
A3�
MAN4
�MA
N5�
• Molecule 5: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain U:
NAG1
NAG2
�BM
A3�
MAN4
�MA
N5�
• Molecule 5: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain d:
Page 24 Full wwPDB EM Validation Report EMD-0404, 6NB7
NAG1
NAG2
BMA3
MAN4
MAN5
�
• Molecule 5: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain q:
NAG1
NAG2
BMA3
MAN4
�MA
N5�
• Molecule 6: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain T:
NAG1
NAG2
BMA3
MAN4
�
• Molecule 6: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain s:
NAG1
NAG2
BMA3
MAN4
• Molecule 7: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain W:
NAG1
NAG2
�
• Molecule 7: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain b:
NAG1
NAG2
�
• Molecule 7: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Page 25 Full wwPDB EM Validation Report EMD-0404, 6NB7
Chain i:NA
G1NA
G2
• Molecule 7: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain k:
NAG1
NAG2
• Molecule 7: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain o:
NAG1
NAG2
• Molecule 7: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain p:
NAG1
NAG2
• Molecule 8: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain f:
NAG1
NAG2
BMA3
MAN4
�
• Molecule 8: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
Chain g:
NAG1
NAG2
BMA3
�MA
N4�
Page 26 Full wwPDB EM Validation Report EMD-0404, 6NB7
4 Experimental information i○
Property Value SourceEM reconstruction method SINGLE PARTICLE DepositorImposed symmetry POINT, C1 DepositorNumber of particles used 19986 DepositorResolution determination method FSC 0.143 CUT-OFF DepositorCTF correction method PHASE FLIPPING AND AMPLITUDE
CORRECTIONDepositor
Microscope FEI TITAN KRIOS DepositorVoltage (kV) 300 DepositorElectron dose (e−/Å2
) 45 DepositorMinimum defocus (nm) Not providedMaximum defocus (nm) Not providedMagnification Not providedImage detector GATAN K2 SUMMIT (4k x 4k) DepositorMaximum map value 6.611 DepositorMinimum map value -3.199 DepositorAverage map value 0.010 DepositorMap value standard deviation 0.129 DepositorRecommended contour level 1.2 DepositorMap size (Å) 526.08, 526.08, 526.08 wwPDBMap dimensions 300, 300, 300 wwPDBMap angles (◦) 90.0, 90.0, 90.0 wwPDBPixel spacing (Å) 1.7536, 1.7536, 1.7536 Depositor
Page 27 Full wwPDB EM Validation Report EMD-0404, 6NB7
5 Model quality i○
5.1 Standard geometry i○
Bond lengths and bond angles in the following residue types are not validated in this section:BMA, NAG, MAN
The Z score for a bond length (or angle) is the number of standard deviations the observed valueis removed from the expected value. A bond length (or angle) with |Z| > 5 is considered anoutlier worth inspection. RMSZ is the root-mean-square of all Z scores of the bond lengths (orangles).
Mol Chain Bond lengths Bond anglesRMSZ #|Z| >5 RMSZ #|Z| >5
1 A 0.54 0/6733 0.56 0/92741 B 0.54 0/6542 0.58 2/9007 (0.0%)1 C 0.53 0/6522 0.57 0/90022 D 0.42 0/615 0.51 0/8552 G 0.43 0/615 0.50 0/8552 H 0.42 0/615 0.50 0/8553 E 0.42 0/564 0.52 0/7873 I 0.41 0/564 0.52 0/7873 L 0.41 0/564 0.52 0/787All All 0.52 0/23334 0.56 2/32209 (0.0%)
There are no bond length outliers.
All (2) bond angle outliers are listed below:
Mol Chain Res Type Atoms Z Observed(o) Ideal(o)1 B 808 VAL CG1-CB-CG2 12.31 130.59 110.901 B 784 PHE N-CA-CB -8.57 95.17 110.60
There are no chirality outliers.
There are no planarity outliers.
5.2 Too-close contacts i○
Due to software issues we are unable to calculate clashes - this section is therefore empty.
Page 28 Full wwPDB EM Validation Report EMD-0404, 6NB7
5.3 Torsion angles i○
5.3.1 Protein backbone i○
In the following table, the Percentiles column shows the percent Ramachandran outliers of thechain as a percentile score with respect to all PDB entries followed by that with respect to all EMentries.
The Analysed column shows the number of residues for which the backbone conformation wasanalysed, and the total number of residues.
Mol Chain Analysed Favoured Allowed Outliers Percentiles
1 A 1033/1263 (82%) 990 (96%) 39 (4%) 4 (0%) 34 72
1 B 1012/1263 (80%) 973 (96%) 37 (4%) 2 (0%) 47 81
1 C 1032/1263 (82%) 996 (96%) 34 (3%) 2 (0%) 47 81
2 D 121/127 (95%) 120 (99%) 1 (1%) 0 100 100
2 G 121/127 (95%) 120 (99%) 1 (1%) 0 100 100
2 H 121/127 (95%) 119 (98%) 2 (2%) 0 100 100
3 E 108/112 (96%) 105 (97%) 3 (3%) 0 100 100
3 I 108/112 (96%) 106 (98%) 2 (2%) 0 100 100
3 L 108/112 (96%) 106 (98%) 2 (2%) 0 100 100
All All 3764/4506 (84%) 3635 (97%) 121 (3%) 8 (0%) 50 81
All (8) Ramachandran outliers are listed below:
Mol Chain Res Type1 A 600 ASP1 A 1081 GLY1 C 318 ASN1 B 1081 GLY1 A 319 ILE1 C 969 PRO1 B 418 GLY1 A 969 PRO
5.3.2 Protein sidechains i○
In the following table, the Percentiles column shows the percent sidechain outliers of the chainas a percentile score with respect to all PDB entries followed by that with respect to all EMentries.
The Analysed column shows the number of residues for which the sidechain conformation was
Page 29 Full wwPDB EM Validation Report EMD-0404, 6NB7
analysed, and the total number of residues.
Mol Chain Analysed Rotameric Outliers Percentiles
1 A 438/1092 (40%) 433 (99%) 5 (1%) 73 85
1 B 410/1092 (38%) 406 (99%) 4 (1%) 76 86
1 C 350/1092 (32%) 346 (99%) 4 (1%) 73 85
2 D 5/106 (5%) 5 (100%) 0 100 100
2 G 5/106 (5%) 5 (100%) 0 100 100
2 H 5/106 (5%) 5 (100%) 0 100 100
3 E 10/99 (10%) 10 (100%) 0 100 100
3 I 10/99 (10%) 10 (100%) 0 100 100
3 L 10/99 (10%) 10 (100%) 0 100 100
All All 1243/3891 (32%) 1230 (99%) 13 (1%) 77 86
All (13) residues with a non-rotameric sidechain are listed below:
Mol Chain Res Type1 A 65 ASN1 A 158 ASN1 A 227 ASN1 A 357 ASN1 A 1080 ASN1 B 109 ASN1 B 119 ASN1 B 269 ASN1 B 1080 ASN1 C 65 ASN1 C 119 ASN1 C 467 CYS1 C 691 ASN
Sometimes sidechains can be flipped to improve hydrogen bonding and reduce clashes. All (6) suchsidechains are listed below:
Mol Chain Res Type1 A 786 GLN1 A 1095 GLN1 B 786 GLN1 B 917 GLN1 C 786 GLN1 C 1095 GLN
Page 30 Full wwPDB EM Validation Report EMD-0404, 6NB7
5.3.3 RNA i○
There are no RNA molecules in this entry.
5.4 Non-standard residues in protein, DNA, RNA chains i○
There are no non-standard protein/DNA/RNA residues in this entry.
5.5 Carbohydrates i○
121 monosaccharides are modelled in this entry.
In the following table, the Counts columns list the number of bonds (or angles) for which Mogulstatistics could be retrieved, the number of bonds (or angles) that are observed in the model andthe number of bonds (or angles) that are defined in the Chemical Component Dictionary. TheLink column lists molecule types, if any, to which the group is linked. The Z score for a bondlength (or angle) is the number of standard deviations the observed value is removed from theexpected value. A bond length (or angle) with |Z| > 2 is considered an outlier worth inspection.RMSZ is the root-mean-square of all Z scores of the bond lengths (or angles).
Mol Type Chain Res Link Bond lengths Bond anglesCounts RMSZ #|Z| > 2 Counts RMSZ #|Z| > 2
4 NAG F 1 1,4 14,14,15 2.15 4 (28%) 17,19,21 1.01 1 (5%)4 NAG F 2 4 14,14,15 2.26 4 (28%) 17,19,21 1.32 2 (11%)4 BMA F 3 4 11,11,12 1.81 2 (18%) 15,15,17 1.00 1 (6%)4 NAG J 1 1,4 14,14,15 2.12 4 (28%) 17,19,21 1.16 3 (17%)4 NAG J 2 4 14,14,15 2.26 4 (28%) 17,19,21 1.13 1 (5%)4 BMA J 3 4 11,11,12 1.82 2 (18%) 15,15,17 1.06 2 (13%)4 NAG K 1 1,4 14,14,15 2.19 4 (28%) 17,19,21 1.20 1 (5%)4 NAG K 2 4 14,14,15 2.30 4 (28%) 17,19,21 1.08 1 (5%)4 BMA K 3 4 11,11,12 1.83 2 (18%) 15,15,17 0.97 04 NAG M 1 1,4 14,14,15 1.83 3 (21%) 17,19,21 1.73 3 (17%)4 NAG M 2 4 14,14,15 2.20 3 (21%) 17,19,21 1.62 5 (29%)4 BMA M 3 4 11,11,12 1.84 2 (18%) 15,15,17 1.04 1 (6%)4 NAG N 1 1,4 14,14,15 2.10 1 (7%) 17,19,21 1.12 1 (5%)4 NAG N 2 4 14,14,15 2.24 4 (28%) 17,19,21 1.36 2 (11%)4 BMA N 3 4 11,11,12 1.84 2 (18%) 15,15,17 1.19 2 (13%)4 NAG O 1 1,4 14,14,15 2.03 2 (14%) 17,19,21 0.90 1 (5%)4 NAG O 2 4 14,14,15 2.32 4 (28%) 17,19,21 1.44 5 (29%)4 BMA O 3 4 11,11,12 1.82 2 (18%) 15,15,17 0.94 1 (6%)
Page 31 Full wwPDB EM Validation Report EMD-0404, 6NB7
Mol Type Chain Res Link Bond lengths Bond anglesCounts RMSZ #|Z| > 2 Counts RMSZ #|Z| > 2
5 NAG P 1 1,5 14,14,15 2.06 2 (14%) 17,19,21 1.14 1 (5%)5 NAG P 2 5 14,14,15 2.29 5 (35%) 17,19,21 1.29 3 (17%)5 BMA P 3 5 11,11,12 1.75 1 (9%) 15,15,17 0.90 05 MAN P 4 5 11,11,12 1.85 2 (18%) 15,15,17 1.47 3 (20%)5 MAN P 5 5 11,11,12 1.84 2 (18%) 15,15,17 1.18 2 (13%)4 NAG Q 1 1,4 14,14,15 2.17 2 (14%) 17,19,21 1.09 2 (11%)4 NAG Q 2 4 14,14,15 2.25 4 (28%) 17,19,21 1.86 5 (29%)4 BMA Q 3 4 11,11,12 1.81 2 (18%) 15,15,17 1.10 1 (6%)5 NAG R 1 1,5 14,14,15 2.11 3 (21%) 17,19,21 1.16 2 (11%)5 NAG R 2 5 14,14,15 2.22 5 (35%) 17,19,21 1.33 3 (17%)5 BMA R 3 5 11,11,12 1.75 2 (18%) 15,15,17 1.19 2 (13%)5 MAN R 4 5 11,11,12 1.84 2 (18%) 15,15,17 1.37 3 (20%)5 MAN R 5 5 11,11,12 1.84 2 (18%) 15,15,17 1.40 3 (20%)5 NAG S 1 1,5 14,14,15 2.01 1 (7%) 17,19,21 1.37 3 (17%)5 NAG S 2 5 14,14,15 2.12 3 (21%) 17,19,21 1.37 3 (17%)5 BMA S 3 5 11,11,12 1.81 2 (18%) 15,15,17 1.22 2 (13%)5 MAN S 4 5 11,11,12 1.84 2 (18%) 15,15,17 1.23 2 (13%)5 MAN S 5 5 11,11,12 1.86 2 (18%) 15,15,17 1.19 3 (20%)6 NAG T 1 1,6 14,14,15 2.13 2 (14%) 17,19,21 0.84 06 NAG T 2 6 14,14,15 2.23 4 (28%) 17,19,21 1.13 3 (17%)6 BMA T 3 6 11,11,12 1.81 3 (27%) 15,15,17 1.00 1 (6%)6 MAN T 4 6 11,11,12 1.85 2 (18%) 15,15,17 1.15 2 (13%)5 NAG U 1 1,5 14,14,15 2.11 3 (21%) 17,19,21 0.84 1 (5%)5 NAG U 2 5 14,14,15 2.22 4 (28%) 17,19,21 1.09 2 (11%)5 BMA U 3 5 11,11,12 1.88 3 (27%) 15,15,17 0.98 1 (6%)5 MAN U 4 5 11,11,12 1.77 1 (9%) 15,15,17 1.23 3 (20%)5 MAN U 5 5 11,11,12 1.83 2 (18%) 15,15,17 1.13 1 (6%)4 NAG V 1 1,4 14,14,15 2.26 4 (28%) 17,19,21 0.96 1 (5%)4 NAG V 2 4 14,14,15 2.26 4 (28%) 17,19,21 1.19 2 (11%)4 BMA V 3 4 11,11,12 1.82 2 (18%) 15,15,17 1.05 2 (13%)7 NAG W 1 1,7 14,14,15 2.18 3 (21%) 17,19,21 1.15 2 (11%)7 NAG W 2 7 14,14,15 2.27 4 (28%) 17,19,21 1.05 1 (5%)4 NAG X 1 1,4 14,14,15 2.12 3 (21%) 17,19,21 1.41 2 (11%)4 NAG X 2 4 14,14,15 2.33 4 (28%) 17,19,21 1.55 3 (17%)4 BMA X 3 4 11,11,12 1.85 2 (18%) 15,15,17 1.08 2 (13%)
Page 32 Full wwPDB EM Validation Report EMD-0404, 6NB7
Mol Type Chain Res Link Bond lengths Bond anglesCounts RMSZ #|Z| > 2 Counts RMSZ #|Z| > 2
4 NAG Y 1 1,4 14,14,15 2.12 3 (21%) 17,19,21 0.84 04 NAG Y 2 4 14,14,15 2.28 5 (35%) 17,19,21 1.71 3 (17%)4 BMA Y 3 4 11,11,12 1.83 2 (18%) 15,15,17 1.03 1 (6%)4 NAG Z 1 1,4 14,14,15 2.36 2 (14%) 17,19,21 0.96 1 (5%)4 NAG Z 2 4 14,14,15 2.32 4 (28%) 17,19,21 1.26 2 (11%)4 BMA Z 3 4 11,11,12 1.83 2 (18%) 15,15,17 1.03 2 (13%)4 NAG a 1 1,4 14,14,15 2.15 3 (21%) 17,19,21 1.10 1 (5%)4 NAG a 2 4 14,14,15 2.25 4 (28%) 17,19,21 1.79 5 (29%)4 BMA a 3 4 11,11,12 1.82 2 (18%) 15,15,17 1.11 2 (13%)7 NAG b 1 1,7 14,14,15 2.10 3 (21%) 17,19,21 1.22 1 (5%)7 NAG b 2 7 14,14,15 2.20 2 (14%) 17,19,21 1.23 2 (11%)4 NAG c 1 1,4 14,14,15 2.16 1 (7%) 17,19,21 0.67 04 NAG c 2 4 14,14,15 2.17 2 (14%) 17,19,21 0.85 04 BMA c 3 4 11,11,12 1.86 2 (18%) 15,15,17 1.03 1 (6%)5 NAG d 1 1,5 14,14,15 2.00 2 (14%) 17,19,21 0.80 05 NAG d 2 5 14,14,15 2.18 5 (35%) 17,19,21 1.43 3 (17%)5 BMA d 3 5 11,11,12 1.69 2 (18%) 15,15,17 1.07 1 (6%)5 MAN d 4 5 11,11,12 1.91 3 (27%) 15,15,17 1.40 3 (20%)5 MAN d 5 5 11,11,12 1.87 2 (18%) 15,15,17 1.06 1 (6%)4 NAG e 1 1,4 14,14,15 2.13 3 (21%) 17,19,21 0.81 1 (5%)4 NAG e 2 4 14,14,15 2.20 3 (21%) 17,19,21 1.40 4 (23%)4 BMA e 3 4 11,11,12 1.85 2 (18%) 15,15,17 1.09 2 (13%)8 NAG f 1 1,8 14,14,15 2.07 3 (21%) 17,19,21 1.02 2 (11%)8 NAG f 2 8 14,14,15 2.14 3 (21%) 17,19,21 0.89 08 BMA f 3 8 11,11,12 1.89 3 (27%) 15,15,17 1.06 1 (6%)8 MAN f 4 8 11,11,12 1.87 2 (18%) 15,15,17 1.28 3 (20%)8 NAG g 1 1,8 14,14,15 2.12 4 (28%) 17,19,21 0.88 08 NAG g 2 8 14,14,15 2.23 4 (28%) 17,19,21 1.48 3 (17%)8 BMA g 3 8 11,11,12 1.82 3 (27%) 15,15,17 0.84 08 MAN g 4 8 11,11,12 1.83 2 (18%) 15,15,17 1.18 2 (13%)4 NAG h 1 1,4 14,14,15 2.16 2 (14%) 17,19,21 1.20 1 (5%)4 NAG h 2 4 14,14,15 2.25 4 (28%) 17,19,21 1.80 4 (23%)4 BMA h 3 4 11,11,12 1.83 2 (18%) 15,15,17 0.95 1 (6%)7 NAG i 1 1,7 14,14,15 2.02 1 (7%) 17,19,21 1.19 2 (11%)7 NAG i 2 7 14,14,15 2.24 3 (21%) 17,19,21 0.76 0
Page 33 Full wwPDB EM Validation Report EMD-0404, 6NB7
Mol Type Chain Res Link Bond lengths Bond anglesCounts RMSZ #|Z| > 2 Counts RMSZ #|Z| > 2
4 NAG j 1 1,4 14,14,15 2.12 4 (28%) 17,19,21 0.86 1 (5%)4 NAG j 2 4 14,14,15 2.25 3 (21%) 17,19,21 1.68 4 (23%)4 BMA j 3 4 11,11,12 1.81 2 (18%) 15,15,17 1.09 2 (13%)7 NAG k 1 1,7 14,14,15 2.17 4 (28%) 17,19,21 2.10 2 (11%)7 NAG k 2 7 14,14,15 2.24 2 (14%) 17,19,21 1.23 2 (11%)4 NAG l 1 1,4 14,14,15 2.03 4 (28%) 17,19,21 1.05 1 (5%)4 NAG l 2 4 14,14,15 2.13 4 (28%) 17,19,21 1.45 3 (17%)4 BMA l 3 4 11,11,12 1.86 2 (18%) 15,15,17 1.20 3 (20%)4 NAG m 1 1,4 14,14,15 2.10 2 (14%) 17,19,21 1.11 3 (17%)4 NAG m 2 4 14,14,15 2.24 4 (28%) 17,19,21 1.09 2 (11%)4 BMA m 3 4 11,11,12 1.84 2 (18%) 15,15,17 1.05 2 (13%)4 NAG n 1 1,4 14,14,15 2.12 3 (21%) 17,19,21 0.87 04 NAG n 2 4 14,14,15 2.27 4 (28%) 17,19,21 1.09 2 (11%)4 BMA n 3 4 11,11,12 1.81 2 (18%) 15,15,17 1.02 1 (6%)7 NAG o 1 1,7 14,14,15 2.18 2 (14%) 17,19,21 0.91 1 (5%)7 NAG o 2 7 14,14,15 2.16 2 (14%) 17,19,21 1.13 1 (5%)7 NAG p 1 1,7 14,14,15 2.11 3 (21%) 17,19,21 0.90 1 (5%)7 NAG p 2 7 14,14,15 2.24 3 (21%) 17,19,21 1.21 2 (11%)5 NAG q 1 1,5 14,14,15 2.15 3 (21%) 17,19,21 1.11 2 (11%)5 NAG q 2 5 14,14,15 2.23 2 (14%) 17,19,21 1.51 3 (17%)5 BMA q 3 5 11,11,12 1.63 2 (18%) 15,15,17 1.44 3 (20%)5 MAN q 4 5 11,11,12 1.82 3 (27%) 15,15,17 1.15 2 (13%)5 MAN q 5 5 11,11,12 1.88 2 (18%) 15,15,17 1.18 3 (20%)4 NAG r 1 1,4 14,14,15 2.16 3 (21%) 17,19,21 0.81 1 (5%)4 NAG r 2 4 14,14,15 2.20 4 (28%) 17,19,21 1.40 2 (11%)4 BMA r 3 4 11,11,12 1.86 2 (18%) 15,15,17 1.12 2 (13%)6 NAG s 1 1,6 14,14,15 2.21 4 (28%) 17,19,21 0.95 1 (5%)6 NAG s 2 6 14,14,15 2.16 4 (28%) 17,19,21 1.37 2 (11%)6 BMA s 3 6 11,11,12 1.72 1 (9%) 15,15,17 1.12 1 (6%)6 MAN s 4 6 11,11,12 1.85 2 (18%) 15,15,17 1.29 3 (20%)4 NAG t 1 1,4 14,14,15 2.16 2 (14%) 17,19,21 0.92 1 (5%)4 NAG t 2 4 14,14,15 2.24 4 (28%) 17,19,21 1.12 1 (5%)4 BMA t 3 4 11,11,12 1.83 2 (18%) 15,15,17 1.06 1 (6%)
In the following table, the Chirals column lists the number of chiral outliers, the number of chiral
Page 34 Full wwPDB EM Validation Report EMD-0404, 6NB7
centers analysed, the number of these observed in the model and the number defined in theChemical Component Dictionary. Similar counts are reported in the Torsion and Rings columns.’-’ means no outliers of that kind were identified.
Mol Type Chain Res Link Chirals Torsions Rings4 NAG F 1 1,4 - 2/6/23/26 0/1/1/14 NAG F 2 4 - 0/6/23/26 0/1/1/14 BMA F 3 4 - 1/2/19/22 0/1/1/14 NAG J 1 1,4 - 2/6/23/26 0/1/1/14 NAG J 2 4 - 0/6/23/26 0/1/1/14 BMA J 3 4 - 1/2/19/22 0/1/1/14 NAG K 1 1,4 - 2/6/23/26 0/1/1/14 NAG K 2 4 - 0/6/23/26 0/1/1/14 BMA K 3 4 - 1/2/19/22 0/1/1/14 NAG M 1 1,4 - 3/6/23/26 0/1/1/14 NAG M 2 4 - 1/6/23/26 0/1/1/14 BMA M 3 4 - 1/2/19/22 0/1/1/14 NAG N 1 1,4 - 2/6/23/26 0/1/1/14 NAG N 2 4 - 2/6/23/26 0/1/1/14 BMA N 3 4 - 1/2/19/22 0/1/1/14 NAG O 1 1,4 - 0/6/23/26 0/1/1/14 NAG O 2 4 - 1/6/23/26 0/1/1/14 BMA O 3 4 - 1/2/19/22 0/1/1/15 NAG P 1 1,5 - 0/6/23/26 0/1/1/15 NAG P 2 5 - 2/6/23/26 0/1/1/15 BMA P 3 5 - 2/2/19/22 0/1/1/15 MAN P 4 5 - 1/2/19/22 0/1/1/15 MAN P 5 5 - 1/2/19/22 0/1/1/14 NAG Q 1 1,4 - 1/6/23/26 0/1/1/14 NAG Q 2 4 - 0/6/23/26 0/1/1/14 BMA Q 3 4 - 2/2/19/22 0/1/1/15 NAG R 1 1,5 - 2/6/23/26 0/1/1/15 NAG R 2 5 - 2/6/23/26 0/1/1/15 BMA R 3 5 - 2/2/19/22 0/1/1/15 MAN R 4 5 - 1/2/19/22 0/1/1/15 MAN R 5 5 - 1/2/19/22 0/1/1/15 NAG S 1 1,5 - 0/6/23/26 0/1/1/15 NAG S 2 5 - 1/6/23/26 0/1/1/15 BMA S 3 5 - 2/2/19/22 0/1/1/15 MAN S 4 5 - 1/2/19/22 0/1/1/15 MAN S 5 5 - 1/2/19/22 0/1/1/16 NAG T 1 1,6 - 2/6/23/26 0/1/1/1
Continued on next page...
Page 35 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Type Chain Res Link Chirals Torsions Rings6 NAG T 2 6 - 2/6/23/26 0/1/1/16 BMA T 3 6 - 2/2/19/22 0/1/1/16 MAN T 4 6 - 1/2/19/22 0/1/1/15 NAG U 1 1,5 - 0/6/23/26 0/1/1/15 NAG U 2 5 - 2/6/23/26 0/1/1/15 BMA U 3 5 - 2/2/19/22 0/1/1/15 MAN U 4 5 - 1/2/19/22 0/1/1/15 MAN U 5 5 - 1/2/19/22 0/1/1/14 NAG V 1 1,4 - 2/6/23/26 0/1/1/14 NAG V 2 4 - 0/6/23/26 0/1/1/14 BMA V 3 4 - 1/2/19/22 0/1/1/17 NAG W 1 1,7 - 0/6/23/26 0/1/1/17 NAG W 2 7 - 0/6/23/26 0/1/1/14 NAG X 1 1,4 - 2/6/23/26 0/1/1/14 NAG X 2 4 - 2/6/23/26 0/1/1/14 BMA X 3 4 - 1/2/19/22 0/1/1/14 NAG Y 1 1,4 - 2/6/23/26 0/1/1/14 NAG Y 2 4 - 0/6/23/26 0/1/1/14 BMA Y 3 4 - 1/2/19/22 0/1/1/14 NAG Z 1 1,4 - 1/6/23/26 0/1/1/14 NAG Z 2 4 - 0/6/23/26 0/1/1/14 BMA Z 3 4 - 1/2/19/22 0/1/1/14 NAG a 1 1,4 - 2/6/23/26 0/1/1/14 NAG a 2 4 - 0/6/23/26 0/1/1/14 BMA a 3 4 - 1/2/19/22 0/1/1/17 NAG b 1 1,7 - 0/6/23/26 0/1/1/17 NAG b 2 7 - 2/6/23/26 0/1/1/14 NAG c 1 1,4 - 2/6/23/26 0/1/1/14 NAG c 2 4 - 1/6/23/26 0/1/1/14 BMA c 3 4 - 1/2/19/22 0/1/1/15 NAG d 1 1,5 - 0/6/23/26 0/1/1/15 NAG d 2 5 - 2/6/23/26 0/1/1/15 BMA d 3 5 - 2/2/19/22 0/1/1/15 MAN d 4 5 - 1/2/19/22 0/1/1/15 MAN d 5 5 - 1/2/19/22 0/1/1/14 NAG e 1 1,4 - 0/6/23/26 0/1/1/14 NAG e 2 4 - 2/6/23/26 0/1/1/14 BMA e 3 4 - 1/2/19/22 0/1/1/18 NAG f 1 1,8 - 0/6/23/26 0/1/1/1
Continued on next page...
Page 36 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Type Chain Res Link Chirals Torsions Rings8 NAG f 2 8 - 2/6/23/26 0/1/1/18 BMA f 3 8 - 2/2/19/22 0/1/1/18 MAN f 4 8 - 1/2/19/22 0/1/1/18 NAG g 1 1,8 - 0/6/23/26 0/1/1/18 NAG g 2 8 - 0/6/23/26 0/1/1/18 BMA g 3 8 - 2/2/19/22 0/1/1/18 MAN g 4 8 - 1/2/19/22 0/1/1/14 NAG h 1 1,4 - 1/6/23/26 0/1/1/14 NAG h 2 4 - 0/6/23/26 0/1/1/14 BMA h 3 4 - 1/2/19/22 0/1/1/17 NAG i 1 1,7 - 0/6/23/26 0/1/1/17 NAG i 2 7 - 2/6/23/26 0/1/1/14 NAG j 1 1,4 - 1/6/23/26 0/1/1/14 NAG j 2 4 - 0/6/23/26 0/1/1/14 BMA j 3 4 - 1/2/19/22 0/1/1/17 NAG k 1 1,7 - 1/6/23/26 0/1/1/17 NAG k 2 7 - 2/6/23/26 0/1/1/14 NAG l 1 1,4 - 1/6/23/26 0/1/1/14 NAG l 2 4 - 2/6/23/26 0/1/1/14 BMA l 3 4 - 1/2/19/22 0/1/1/14 NAG m 1 1,4 - 0/6/23/26 0/1/1/14 NAG m 2 4 - 2/6/23/26 0/1/1/14 BMA m 3 4 - 1/2/19/22 0/1/1/14 NAG n 1 1,4 - 0/6/23/26 0/1/1/14 NAG n 2 4 - 0/6/23/26 0/1/1/14 BMA n 3 4 - 1/2/19/22 0/1/1/17 NAG o 1 1,7 - 2/6/23/26 0/1/1/17 NAG o 2 7 - 1/6/23/26 0/1/1/17 NAG p 1 1,7 - 2/6/23/26 0/1/1/17 NAG p 2 7 - 0/6/23/26 0/1/1/15 NAG q 1 1,5 - 1/6/23/26 0/1/1/15 NAG q 2 5 - 2/6/23/26 0/1/1/15 BMA q 3 5 - 1/2/19/22 0/1/1/15 MAN q 4 5 - 1/2/19/22 0/1/1/15 MAN q 5 5 - 1/2/19/22 0/1/1/14 NAG r 1 1,4 - 0/6/23/26 0/1/1/14 NAG r 2 4 - 0/6/23/26 0/1/1/14 BMA r 3 4 - 1/2/19/22 0/1/1/16 NAG s 1 1,6 - 2/6/23/26 0/1/1/16 NAG s 2 6 - 0/6/23/26 0/1/1/1
Continued on next page...
Page 37 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Type Chain Res Link Chirals Torsions Rings6 BMA s 3 6 - 2/2/19/22 0/1/1/16 MAN s 4 6 - 2/2/19/22 0/1/1/14 NAG t 1 1,4 - 1/6/23/26 0/1/1/14 NAG t 2 4 - 0/6/23/26 0/1/1/14 BMA t 3 4 - 1/2/19/22 0/1/1/1
All (334) bond length outliers are listed below:
Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)4 Z 1 NAG O5-C1 7.65 1.55 1.434 K 2 NAG O5-C1 7.39 1.55 1.434 O 2 NAG O5-C1 7.36 1.55 1.434 Z 2 NAG O5-C1 7.31 1.55 1.434 X 2 NAG O5-C1 7.27 1.55 1.437 i 2 NAG O5-C1 7.26 1.55 1.434 n 2 NAG O5-C1 7.24 1.55 1.437 W 2 NAG O5-C1 7.21 1.55 1.434 j 2 NAG O5-C1 7.21 1.55 1.434 M 2 NAG O5-C1 7.18 1.55 1.434 F 2 NAG O5-C1 7.14 1.55 1.434 V 2 NAG O5-C1 7.14 1.55 1.437 p 2 NAG O5-C1 7.14 1.55 1.437 o 1 NAG O5-C1 7.13 1.55 1.434 h 2 NAG O5-C1 7.12 1.55 1.434 V 1 NAG O5-C1 7.12 1.55 1.434 Q 2 NAG O5-C1 7.11 1.55 1.434 Y 2 NAG O5-C1 7.10 1.55 1.434 a 2 NAG O5-C1 7.08 1.55 1.434 c 1 NAG O5-C1 7.08 1.55 1.437 b 2 NAG O5-C1 7.07 1.55 1.434 t 1 NAG O5-C1 7.06 1.55 1.434 J 2 NAG O5-C1 7.05 1.55 1.434 N 2 NAG O5-C1 7.05 1.55 1.434 t 2 NAG O5-C1 7.04 1.55 1.436 s 1 NAG O5-C1 7.04 1.55 1.437 k 2 NAG O5-C1 7.03 1.54 1.437 W 1 NAG O5-C1 7.03 1.54 1.435 U 2 NAG O5-C1 7.02 1.54 1.434 Q 1 NAG O5-C1 7.02 1.54 1.434 r 2 NAG O5-C1 7.02 1.54 1.434 c 2 NAG O5-C1 7.02 1.54 1.436 T 2 NAG O5-C1 6.98 1.54 1.43
Continued on next page...
Page 38 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)4 e 2 NAG O5-C1 6.92 1.54 1.434 r 1 NAG O5-C1 6.92 1.54 1.434 a 1 NAG O5-C1 6.91 1.54 1.434 m 2 NAG O5-C1 6.91 1.54 1.434 K 1 NAG O5-C1 6.86 1.54 1.434 N 1 NAG O5-C1 6.86 1.54 1.435 P 2 NAG O5-C1 6.84 1.54 1.436 T 1 NAG O5-C1 6.82 1.54 1.434 e 1 NAG O5-C1 6.82 1.54 1.435 q 2 NAG O5-C1 6.82 1.54 1.438 f 2 NAG O5-C1 6.81 1.54 1.434 n 1 NAG O5-C1 6.81 1.54 1.437 o 2 NAG O5-C1 6.78 1.54 1.435 U 1 NAG O5-C1 6.78 1.54 1.438 g 2 NAG O5-C1 6.76 1.54 1.434 Y 1 NAG O5-C1 6.75 1.54 1.434 F 1 NAG O5-C1 6.75 1.54 1.437 p 1 NAG O5-C1 6.74 1.54 1.434 j 1 NAG O5-C1 6.73 1.54 1.435 q 1 NAG O5-C1 6.72 1.54 1.436 s 2 NAG O5-C1 6.69 1.54 1.437 b 1 NAG O5-C1 6.69 1.54 1.437 i 1 NAG O5-C1 6.68 1.54 1.434 h 1 NAG O5-C1 6.64 1.54 1.434 l 2 NAG O5-C1 6.62 1.54 1.434 m 1 NAG O5-C1 6.62 1.54 1.438 g 1 NAG O5-C1 6.61 1.54 1.435 R 1 NAG O5-C1 6.60 1.54 1.435 S 1 NAG O5-C1 6.58 1.54 1.434 J 1 NAG O5-C1 6.58 1.54 1.438 f 1 NAG O5-C1 6.57 1.54 1.435 R 2 NAG O5-C1 6.56 1.54 1.434 X 1 NAG O5-C1 6.55 1.54 1.435 d 2 NAG O5-C1 6.52 1.54 1.435 P 1 NAG O5-C1 6.48 1.54 1.434 O 1 NAG O5-C1 6.42 1.54 1.435 S 2 NAG O5-C1 6.42 1.54 1.435 d 1 NAG O5-C1 6.36 1.53 1.437 k 1 NAG O5-C1 6.32 1.53 1.434 M 1 NAG O5-C1 5.85 1.53 1.434 l 1 NAG O5-C1 5.73 1.52 1.435 U 3 BMA O2-C2 -4.41 1.34 1.43
Continued on next page...
Page 39 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)8 f 3 BMA O2-C2 -4.37 1.34 1.435 d 5 MAN O2-C2 -4.23 1.34 1.435 S 4 MAN O2-C2 -4.20 1.34 1.435 R 5 MAN O2-C2 -4.19 1.34 1.435 d 4 MAN O2-C2 -4.18 1.34 1.434 O 3 BMA O2-C2 -4.17 1.34 1.436 T 3 BMA O2-C2 -4.14 1.34 1.435 P 4 MAN O2-C2 -4.13 1.34 1.435 P 5 MAN O2-C2 -4.13 1.34 1.435 U 5 MAN O2-C2 -4.13 1.34 1.434 l 3 BMA O2-C2 -4.13 1.34 1.434 c 3 BMA O2-C2 -4.11 1.34 1.434 X 3 BMA O2-C2 -4.11 1.34 1.434 M 3 BMA O2-C2 -4.11 1.34 1.435 q 5 MAN O2-C2 -4.11 1.34 1.434 h 3 BMA O2-C2 -4.10 1.34 1.434 N 3 BMA O2-C2 -4.10 1.34 1.434 t 3 BMA O2-C2 -4.09 1.34 1.435 S 5 MAN O2-C2 -4.09 1.34 1.434 Y 3 BMA O2-C2 -4.09 1.34 1.434 J 3 BMA O2-C2 -4.09 1.34 1.438 g 4 MAN O2-C2 -4.09 1.34 1.435 U 4 MAN O2-C2 -4.08 1.34 1.434 e 3 BMA O2-C2 -4.08 1.34 1.438 g 3 BMA O2-C2 -4.08 1.34 1.436 T 4 MAN O2-C2 -4.08 1.34 1.434 r 3 BMA O2-C2 -4.08 1.34 1.434 V 3 BMA O2-C2 -4.07 1.34 1.435 R 4 MAN O2-C2 -4.07 1.34 1.434 F 3 BMA O2-C2 -4.07 1.34 1.438 f 4 MAN O2-C2 -4.06 1.34 1.434 K 3 BMA O2-C2 -4.05 1.34 1.434 Q 3 BMA O2-C2 -4.05 1.34 1.434 n 3 BMA O2-C2 -4.05 1.34 1.436 s 3 BMA O2-C2 -4.04 1.34 1.436 s 4 MAN O2-C2 -4.04 1.34 1.434 a 3 BMA O2-C2 -4.04 1.34 1.434 Z 3 BMA O2-C2 -4.03 1.34 1.434 j 3 BMA O2-C2 -4.02 1.34 1.435 S 3 BMA O2-C2 -4.02 1.34 1.434 m 3 BMA O2-C2 -4.01 1.34 1.435 R 3 BMA O2-C2 -3.91 1.35 1.43
Continued on next page...
Page 40 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)5 P 3 BMA O2-C2 -3.88 1.35 1.435 q 4 MAN O2-C2 -3.84 1.35 1.435 d 3 BMA O2-C2 -3.82 1.35 1.435 q 2 NAG C4-C3 3.46 1.61 1.525 q 3 BMA O2-C2 -3.40 1.36 1.437 k 1 NAG C3-C2 -2.96 1.46 1.525 S 2 NAG C4-C3 2.92 1.59 1.525 P 2 NAG C4-C3 2.83 1.59 1.524 l 1 NAG C4-C3 2.77 1.59 1.524 m 2 NAG C4-C3 2.72 1.59 1.526 s 2 NAG C4-C3 2.63 1.59 1.525 R 2 NAG C1-C2 -2.60 1.48 1.525 R 2 NAG C4-C3 2.60 1.58 1.528 g 2 NAG C4-C3 2.59 1.58 1.524 l 3 BMA C2-C3 -2.56 1.48 1.524 Y 3 BMA C2-C3 -2.55 1.48 1.524 X 1 NAG C3-C2 -2.55 1.47 1.525 d 2 NAG C4-C3 2.55 1.58 1.524 l 2 NAG C4-C3 2.52 1.58 1.524 N 2 NAG C4-C3 2.51 1.58 1.524 l 1 NAG C1-C2 -2.51 1.48 1.525 q 5 MAN C2-C3 -2.49 1.48 1.525 q 3 BMA C2-C3 -2.49 1.48 1.528 f 4 MAN C2-C3 -2.49 1.48 1.524 h 1 NAG C4-C3 2.49 1.58 1.525 P 2 NAG C1-C2 -2.49 1.48 1.524 Z 2 NAG C4-C3 2.49 1.58 1.524 e 2 NAG C4-C3 2.47 1.58 1.528 g 2 NAG C3-C2 -2.47 1.47 1.524 X 3 BMA C2-C3 -2.47 1.48 1.525 R 1 NAG C3-C2 -2.46 1.47 1.524 h 2 NAG C4-C3 2.45 1.58 1.524 t 2 NAG C4-C3 2.45 1.58 1.524 X 2 NAG C3-C2 -2.44 1.47 1.524 O 2 NAG C4-C3 2.42 1.58 1.524 j 2 NAG C4-C3 2.41 1.58 1.525 S 3 BMA C2-C3 -2.41 1.49 1.524 r 3 BMA C2-C3 -2.41 1.49 1.524 V 2 NAG C4-C3 2.41 1.58 1.524 V 1 NAG C4-C5 2.40 1.58 1.534 Q 1 NAG C3-C2 -2.40 1.47 1.524 n 2 NAG C4-C3 2.40 1.58 1.52
Continued on next page...
Page 41 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)4 m 3 BMA C2-C3 -2.40 1.49 1.524 Y 2 NAG C3-C2 -2.39 1.47 1.524 K 1 NAG C3-C2 -2.39 1.47 1.524 O 2 NAG C4-C5 2.39 1.58 1.537 o 1 NAG C3-C2 -2.39 1.47 1.524 J 2 NAG C4-C3 2.38 1.58 1.524 Z 3 BMA C2-C3 -2.38 1.49 1.524 K 1 NAG C4-C3 2.38 1.58 1.524 r 2 NAG C4-C3 2.38 1.58 1.525 d 2 NAG C4-C5 2.38 1.58 1.534 K 2 NAG C4-C3 2.38 1.58 1.526 T 4 MAN C2-C3 -2.37 1.49 1.524 J 2 NAG C3-C2 -2.37 1.47 1.525 P 2 NAG C4-C5 2.37 1.58 1.534 Y 2 NAG C4-C3 2.37 1.58 1.524 a 2 NAG C4-C5 2.37 1.58 1.534 F 2 NAG C4-C3 2.36 1.58 1.525 d 5 MAN C2-C3 -2.36 1.49 1.524 h 3 BMA C2-C3 -2.36 1.49 1.527 W 1 NAG C3-C2 -2.36 1.47 1.524 Y 1 NAG C3-C2 -2.36 1.47 1.524 a 2 NAG C4-C3 2.35 1.58 1.527 W 2 NAG C4-C3 2.35 1.58 1.524 N 3 BMA C2-C3 -2.35 1.49 1.525 d 4 MAN C2-C3 -2.34 1.49 1.525 P 5 MAN C2-C3 -2.34 1.49 1.525 P 4 MAN C2-C3 -2.34 1.49 1.527 W 2 NAG C3-C2 -2.34 1.47 1.524 J 1 NAG C3-C2 -2.33 1.47 1.524 c 3 BMA C2-C3 -2.33 1.49 1.525 S 5 MAN C2-C3 -2.33 1.49 1.528 f 2 NAG C4-C3 2.32 1.58 1.524 X 2 NAG C4-C5 2.32 1.57 1.534 O 3 BMA C2-C3 -2.32 1.49 1.524 F 3 BMA C2-C3 -2.32 1.49 1.526 T 2 NAG C4-C3 2.32 1.58 1.525 R 2 NAG C3-C2 -2.32 1.47 1.525 q 1 NAG C4-C5 2.31 1.57 1.534 X 2 NAG C4-C3 2.31 1.58 1.524 K 3 BMA C2-C3 -2.30 1.49 1.524 j 1 NAG C4-C3 2.30 1.58 1.524 Q 3 BMA C2-C3 -2.30 1.49 1.52
Continued on next page...
Page 42 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)5 d 3 BMA C2-C3 -2.30 1.49 1.524 e 3 BMA C2-C3 -2.30 1.49 1.524 V 1 NAG C3-C2 -2.29 1.47 1.525 U 1 NAG C3-C2 -2.29 1.47 1.526 T 2 NAG C3-C2 -2.29 1.47 1.526 T 1 NAG C3-C2 -2.29 1.47 1.527 p 1 NAG C3-C2 -2.28 1.47 1.524 r 1 NAG C3-C2 -2.27 1.47 1.524 J 3 BMA C2-C3 -2.27 1.49 1.524 F 1 NAG C3-C2 -2.26 1.47 1.525 R 1 NAG C4-C5 2.26 1.57 1.535 q 4 MAN C2-C3 -2.26 1.49 1.524 N 2 NAG C4-C5 2.26 1.57 1.535 U 2 NAG C4-C3 2.25 1.58 1.524 t 3 BMA C2-C3 -2.25 1.49 1.524 e 1 NAG C3-C2 -2.25 1.47 1.524 V 3 BMA C2-C3 -2.25 1.49 1.526 s 4 MAN C2-C3 -2.24 1.49 1.524 j 2 NAG C4-C5 2.24 1.57 1.534 t 1 NAG C3-C2 -2.24 1.47 1.525 q 1 NAG C3-C2 -2.24 1.47 1.525 P 1 NAG C4-C3 2.24 1.58 1.524 Z 2 NAG C3-C2 -2.24 1.47 1.525 R 5 MAN C2-C3 -2.24 1.49 1.524 M 2 NAG C4-C3 2.23 1.58 1.524 m 2 NAG C4-C5 2.23 1.57 1.534 M 1 NAG C4-C3 2.23 1.58 1.527 k 2 NAG C3-C2 -2.23 1.47 1.527 o 2 NAG C4-C3 2.23 1.58 1.524 a 3 BMA C2-C3 -2.23 1.49 1.524 e 2 NAG C4-C5 2.23 1.57 1.534 X 1 NAG C4-C5 2.22 1.57 1.534 F 1 NAG C4-C3 2.22 1.58 1.526 s 1 NAG C4-C5 2.22 1.57 1.538 g 4 MAN C2-C3 -2.21 1.49 1.527 k 1 NAG C4-C3 2.21 1.57 1.524 a 1 NAG C3-C2 -2.20 1.47 1.525 U 5 MAN C2-C3 -2.20 1.49 1.525 R 3 BMA C4-C5 2.20 1.57 1.534 K 2 NAG C3-C2 -2.20 1.47 1.524 n 2 NAG C4-C5 2.20 1.57 1.538 g 1 NAG C3-C2 -2.19 1.47 1.52
Continued on next page...
Page 43 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)4 F 2 NAG C3-C2 -2.19 1.47 1.528 g 3 BMA C2-C3 -2.19 1.49 1.524 F 2 NAG C4-C5 2.19 1.57 1.534 l 2 NAG C3-C2 -2.19 1.47 1.524 m 2 NAG C3-C2 -2.18 1.47 1.524 n 2 NAG C3-C2 -2.18 1.47 1.525 S 4 MAN C2-C3 -2.18 1.49 1.528 g 2 NAG C1-C2 -2.18 1.49 1.527 b 1 NAG C4-C3 2.18 1.57 1.524 n 3 BMA C2-C3 -2.18 1.49 1.524 M 3 BMA C2-C3 -2.18 1.49 1.524 J 1 NAG C4-C5 2.18 1.57 1.534 J 2 NAG C4-C5 2.17 1.57 1.536 s 1 NAG C3-C2 -2.17 1.47 1.527 p 1 NAG C4-C5 2.17 1.57 1.534 a 1 NAG C4-C3 2.17 1.57 1.525 U 3 BMA O5-C1 2.17 1.47 1.434 h 2 NAG C4-C5 2.17 1.57 1.534 t 2 NAG C3-C2 -2.17 1.47 1.528 f 3 BMA C6-C5 2.17 1.59 1.514 c 2 NAG C3-C2 -2.17 1.47 1.525 U 1 NAG C4-C3 2.17 1.57 1.524 r 1 NAG C4-C3 2.16 1.57 1.525 d 2 NAG C3-C2 -2.16 1.47 1.524 K 2 NAG C4-C5 2.16 1.57 1.534 Z 2 NAG C4-C5 2.16 1.57 1.534 t 2 NAG C4-C5 2.16 1.57 1.534 Y 2 NAG C4-C5 2.15 1.57 1.534 Z 1 NAG C3-C2 -2.15 1.47 1.524 O 2 NAG C3-C2 -2.15 1.47 1.524 e 1 NAG C4-C3 2.15 1.57 1.528 g 1 NAG C4-C5 2.15 1.57 1.534 Q 2 NAG C4-C5 2.14 1.57 1.535 S 2 NAG C1-C2 -2.14 1.49 1.524 j 3 BMA C2-C3 -2.14 1.49 1.525 U 3 BMA C6-C5 2.13 1.59 1.514 Q 2 NAG C4-C3 2.13 1.57 1.528 f 1 NAG C3-C2 -2.13 1.48 1.524 V 2 NAG C4-C5 2.13 1.57 1.537 b 1 NAG C3-C2 -2.13 1.48 1.525 q 4 MAN C6-C5 2.13 1.59 1.514 M 1 NAG C4-C5 2.13 1.57 1.53
Continued on next page...
Page 44 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)6 s 2 NAG C3-C2 -2.12 1.48 1.524 l 2 NAG C4-C5 2.12 1.57 1.537 b 2 NAG C3-C2 -2.12 1.48 1.525 d 4 MAN C6-C5 2.12 1.59 1.514 Q 2 NAG C3-C2 -2.12 1.48 1.527 p 2 NAG C3-C2 -2.11 1.48 1.527 W 1 NAG C4-C5 2.11 1.57 1.534 N 2 NAG C3-C2 -2.11 1.48 1.527 W 2 NAG C4-C5 2.11 1.57 1.534 a 2 NAG C3-C2 -2.11 1.48 1.524 V 2 NAG C3-C2 -2.10 1.48 1.525 d 1 NAG C4-C3 2.10 1.57 1.524 n 1 NAG C3-C2 -2.10 1.48 1.524 m 1 NAG C4-C3 2.09 1.57 1.526 s 2 NAG C1-C2 -2.09 1.49 1.524 J 1 NAG C4-C3 2.09 1.57 1.524 F 1 NAG C4-C5 2.08 1.57 1.536 s 1 NAG C4-C3 2.08 1.57 1.524 h 2 NAG C3-C2 -2.08 1.48 1.527 i 2 NAG C3-C2 -2.07 1.48 1.527 i 2 NAG C4-C3 2.07 1.57 1.528 f 1 NAG C4-C3 2.07 1.57 1.524 l 1 NAG C3-C2 -2.07 1.48 1.524 O 1 NAG C4-C3 2.07 1.57 1.528 f 3 BMA C2-C3 -2.06 1.49 1.525 R 4 MAN C2-C3 -2.06 1.49 1.524 M 2 NAG C4-C5 2.06 1.57 1.535 U 2 NAG C3-C2 -2.06 1.48 1.528 f 2 NAG C3-C2 -2.06 1.48 1.526 T 2 NAG C1-C2 -2.06 1.49 1.525 d 2 NAG C1-C2 -2.05 1.49 1.524 n 1 NAG C4-C3 2.05 1.57 1.525 U 2 NAG C1-C2 -2.05 1.49 1.524 Y 2 NAG C1-C2 -2.05 1.49 1.525 R 2 NAG C4-C5 2.04 1.57 1.534 j 1 NAG C3-C2 -2.04 1.48 1.524 j 1 NAG C4-C5 2.04 1.57 1.535 P 2 NAG C3-C2 -2.04 1.48 1.527 p 2 NAG C1-C2 -2.04 1.49 1.526 T 3 BMA C2-C3 -2.03 1.49 1.524 K 1 NAG C4-C5 2.03 1.57 1.534 Y 1 NAG C4-C3 2.03 1.57 1.52
Continued on next page...
Page 45 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)6 T 3 BMA C6-C5 2.03 1.58 1.514 r 2 NAG C3-C2 -2.03 1.48 1.528 g 1 NAG C4-C3 2.02 1.57 1.528 g 3 BMA C6-C5 2.02 1.58 1.517 k 1 NAG C4-C5 2.01 1.57 1.534 r 2 NAG C4-C5 2.00 1.57 1.534 V 1 NAG C4-C3 2.00 1.57 1.52
All (221) bond angle outliers are listed below:
Mol Chain Res Type Atoms Z Observed(o) Ideal(o)7 k 1 NAG C1-O5-C5 -6.62 103.22 112.194 Q 2 NAG C4-C3-C2 -5.41 103.09 111.024 Y 2 NAG C4-C3-C2 -4.78 104.02 111.024 X 2 NAG C4-C3-C2 -4.67 104.17 111.027 k 1 NAG C4-C3-C2 -4.23 104.83 111.024 h 2 NAG C4-C3-C2 -4.09 105.02 111.024 a 2 NAG C4-C3-C2 -4.06 105.07 111.027 b 1 NAG C1-O5-C5 -3.96 106.82 112.194 r 2 NAG C4-C3-C2 -3.91 105.29 111.024 F 2 NAG C4-C3-C2 -3.84 105.39 111.024 Z 2 NAG C4-C3-C2 -3.79 105.46 111.024 l 2 NAG C4-C3-C2 -3.75 105.53 111.024 M 1 NAG C3-C4-C5 -3.71 103.63 110.244 a 2 NAG C1-O5-C5 3.69 117.19 112.194 h 1 NAG C1-O5-C5 -3.69 107.20 112.194 j 2 NAG C1-O5-C5 3.61 117.08 112.194 N 2 NAG C4-C3-C2 -3.60 105.74 111.025 P 1 NAG C1-O5-C5 -3.56 107.38 112.194 M 2 NAG C4-C3-C2 -3.54 105.83 111.024 h 2 NAG C1-O5-C5 3.52 116.96 112.194 j 2 NAG C4-C3-C2 -3.48 105.92 111.024 V 2 NAG C4-C3-C2 -3.47 105.93 111.027 k 2 NAG C4-C3-C2 -3.42 106.00 111.024 O 2 NAG C4-C3-C2 -3.42 106.01 111.027 p 2 NAG C4-C3-C2 -3.42 106.01 111.024 e 2 NAG C4-C3-C2 -3.38 106.06 111.024 M 1 NAG C4-C3-C2 3.35 115.92 111.024 K 1 NAG C1-O5-C5 -3.31 107.71 112.194 X 1 NAG C1-O5-C5 -3.27 107.76 112.194 M 2 NAG O5-C1-C2 -3.25 106.16 111.295 S 2 NAG C1-O5-C5 -3.24 107.81 112.19
Continued on next page...
Page 46 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(o) Ideal(o)5 P 4 MAN C1-C2-C3 3.21 113.61 109.674 t 2 NAG C4-C3-C2 -3.20 106.33 111.024 M 1 NAG O5-C5-C6 -3.18 102.22 107.204 J 2 NAG C4-C3-C2 -3.17 106.37 111.024 h 2 NAG O5-C5-C4 -3.14 103.18 110.837 i 1 NAG O5-C1-C2 -3.14 106.33 111.294 j 2 NAG O5-C5-C4 -3.14 103.19 110.834 a 2 NAG O5-C5-C4 -3.13 103.21 110.835 P 4 MAN C2-C3-C4 -3.13 105.49 110.895 q 2 NAG O5-C1-C2 -3.11 106.38 111.295 R 5 MAN C1-C2-C3 3.10 113.48 109.676 s 2 NAG O5-C1-C2 -3.09 106.40 111.295 S 1 NAG O5-C5-C4 -3.07 103.36 110.834 Y 2 NAG O5-C5-C4 -3.06 103.38 110.835 R 4 MAN C1-C2-C3 3.05 113.42 109.675 S 1 NAG C4-C3-C2 -3.04 106.56 111.025 d 2 NAG C3-C4-C5 -3.01 104.86 110.244 X 1 NAG O4-C4-C3 -3.01 103.39 110.355 q 2 NAG C3-C4-C5 -3.00 104.89 110.244 l 1 NAG C1-O5-C5 -2.97 108.16 112.195 S 4 MAN C2-C3-C4 -2.97 105.76 110.895 d 2 NAG O5-C1-C2 -2.97 106.60 111.297 b 2 NAG C4-C3-C2 -2.92 106.73 111.028 g 2 NAG O5-C1-C2 -2.91 106.69 111.294 e 2 NAG O5-C5-C4 -2.91 103.75 110.838 g 2 NAG C3-C4-C5 -2.89 105.09 110.247 W 2 NAG C4-C3-C2 -2.88 106.79 111.025 U 2 NAG O5-C1-C2 -2.88 106.75 111.294 K 2 NAG C4-C3-C2 -2.86 106.83 111.024 F 1 NAG C1-O5-C5 -2.83 108.35 112.197 o 1 NAG C1-O5-C5 -2.82 108.37 112.194 l 2 NAG O5-C5-C4 -2.81 103.99 110.836 s 4 MAN C1-C2-C3 2.81 113.12 109.675 d 4 MAN C2-C3-C4 -2.80 106.04 110.894 M 2 NAG C1-O5-C5 2.80 115.98 112.195 d 4 MAN C1-C2-C3 2.80 113.10 109.674 h 2 NAG O5-C1-C2 -2.80 106.87 111.298 f 4 MAN C1-C2-C3 2.78 113.08 109.674 Q 2 NAG O5-C1-C2 -2.75 106.94 111.295 S 1 NAG C1-O5-C5 2.74 115.91 112.194 n 2 NAG C4-C3-C2 -2.72 107.03 111.024 O 2 NAG O5-C5-C4 -2.72 104.22 110.83
Continued on next page...
Page 47 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(o) Ideal(o)5 q 3 BMA C1-C2-C3 2.71 113.00 109.675 q 3 BMA C1-O5-C5 2.70 115.85 112.194 Q 2 NAG O5-C5-C4 -2.69 104.29 110.837 i 1 NAG C4-C3-C2 -2.67 107.10 111.024 Q 1 NAG C1-O5-C5 -2.67 108.57 112.194 r 2 NAG O5-C5-C4 -2.66 104.36 110.835 U 4 MAN C2-C3-C4 -2.66 106.30 110.895 q 1 NAG C3-C4-C5 -2.65 105.52 110.247 W 1 NAG O5-C1-C2 -2.65 107.11 111.294 N 1 NAG C3-C4-C5 -2.61 105.58 110.245 R 4 MAN C2-C3-C4 -2.61 106.38 110.895 R 4 MAN O5-C1-C2 -2.59 106.77 110.774 a 1 NAG C1-O5-C5 -2.59 108.68 112.194 Q 3 BMA C2-C3-C4 -2.58 106.44 110.894 O 1 NAG C1-O5-C5 -2.57 108.70 112.197 o 2 NAG C4-C3-C2 -2.57 107.25 111.024 m 2 NAG C4-C3-C2 -2.57 107.25 111.024 X 2 NAG O5-C1-C2 -2.57 107.23 111.297 b 2 NAG O5-C1-C2 -2.57 107.23 111.295 P 2 NAG C4-C3-C2 -2.57 107.26 111.025 R 5 MAN C2-C3-C4 -2.55 106.48 110.894 N 2 NAG O5-C5-C4 -2.55 104.62 110.835 U 3 BMA C2-C3-C4 -2.53 106.51 110.895 P 4 MAN O5-C1-C2 -2.53 106.87 110.776 s 3 BMA C2-C3-C4 -2.52 106.53 110.895 d 4 MAN O5-C1-C2 -2.52 106.88 110.774 J 1 NAG C3-C4-C5 -2.51 105.76 110.245 U 5 MAN C2-C3-C4 -2.51 106.55 110.897 k 2 NAG O5-C1-C2 -2.51 107.33 111.296 s 2 NAG C3-C4-C5 -2.49 105.80 110.245 R 1 NAG C3-C4-C5 -2.49 105.80 110.246 T 2 NAG C4-C3-C2 -2.48 107.38 111.024 j 2 NAG O5-C1-C2 -2.48 107.37 111.298 f 4 MAN C2-C3-C4 -2.48 106.61 110.895 q 2 NAG O4-C4-C3 2.48 116.07 110.354 Z 1 NAG C3-C4-C5 -2.48 105.82 110.245 U 2 NAG C4-C3-C2 -2.47 107.39 111.024 J 1 NAG C1-O5-C5 -2.47 108.85 112.195 q 4 MAN C2-C3-C4 -2.46 106.64 110.894 j 1 NAG C3-C4-C5 -2.45 105.87 110.244 N 3 BMA C2-C3-C4 -2.45 106.66 110.896 T 2 NAG O5-C1-C2 -2.44 107.44 111.29
Continued on next page...
Page 48 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(o) Ideal(o)4 l 3 BMA C2-C3-C4 -2.43 106.69 110.898 g 4 MAN C2-C3-C4 -2.42 106.71 110.895 R 2 NAG C3-C4-C5 -2.42 105.92 110.244 F 2 NAG O5-C5-C4 -2.42 104.95 110.837 W 1 NAG C3-C4-C5 -2.41 105.94 110.247 p 2 NAG O5-C1-C2 -2.41 107.49 111.294 a 2 NAG O5-C1-C2 -2.41 107.49 111.295 R 3 BMA C2-C3-C4 -2.40 106.74 110.894 Y 3 BMA C2-C3-C4 -2.39 106.75 110.894 t 1 NAG C1-O5-C5 -2.39 108.95 112.194 m 2 NAG O5-C5-C4 -2.39 105.01 110.834 c 3 BMA C2-C3-C4 -2.38 106.78 110.895 S 3 BMA C2-C3-C4 -2.38 106.78 110.898 g 2 NAG C1-O5-C5 -2.38 108.97 112.195 P 5 MAN C1-C2-C3 2.37 112.58 109.674 t 3 BMA C2-C3-C4 -2.37 106.79 110.896 s 4 MAN O5-C1-C2 -2.37 107.11 110.775 R 5 MAN O5-C1-C2 -2.35 107.14 110.776 T 4 MAN C1-C2-C3 2.35 112.55 109.675 S 2 NAG O4-C4-C5 -2.34 103.48 109.305 R 3 BMA O5-C1-C2 -2.34 107.16 110.775 P 5 MAN C2-C3-C4 -2.33 106.86 110.894 r 3 BMA C2-C3-C4 -2.33 106.86 110.894 m 1 NAG C3-C4-C5 -2.33 106.09 110.245 U 1 NAG C1-O5-C5 -2.32 109.04 112.195 R 2 NAG O5-C1-C2 -2.31 107.64 111.294 X 3 BMA C2-C3-C4 -2.31 106.90 110.894 m 1 NAG C4-C3-C2 2.31 114.40 111.025 q 5 MAN C2-C3-C4 -2.31 106.91 110.894 M 2 NAG O5-C5-C4 -2.31 105.22 110.834 M 2 NAG O4-C4-C5 2.30 115.00 109.308 f 1 NAG C1-O5-C5 -2.29 109.09 112.194 N 3 BMA O5-C1-C2 -2.29 107.24 110.774 V 3 BMA C2-C3-C4 -2.29 106.94 110.894 m 3 BMA C2-C3-C4 -2.28 106.96 110.895 S 4 MAN C1-C2-C3 2.27 112.45 109.678 g 4 MAN C1-C2-C3 2.27 112.45 109.675 R 1 NAG O4-C4-C3 -2.26 105.12 110.354 Y 2 NAG C1-O5-C5 2.26 115.25 112.195 R 2 NAG C1-O5-C5 -2.25 109.14 112.194 j 3 BMA C2-C3-C4 -2.25 107.00 110.895 S 2 NAG C3-C4-C5 -2.25 106.23 110.24
Continued on next page...
Page 49 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(o) Ideal(o)5 S 5 MAN C2-C3-C4 -2.25 107.01 110.894 Q 2 NAG O4-C4-C5 2.25 114.87 109.305 q 5 MAN O5-C1-C2 -2.24 107.32 110.774 a 3 BMA C2-C3-C4 -2.24 107.03 110.894 F 3 BMA C2-C3-C4 -2.24 107.03 110.894 n 2 NAG O5-C5-C4 -2.23 105.39 110.835 q 3 BMA C2-C3-C4 -2.23 107.03 110.894 e 3 BMA C2-C3-C4 -2.22 107.05 110.895 U 4 MAN O5-C1-C2 -2.22 107.34 110.774 J 3 BMA C2-C3-C4 -2.22 107.05 110.894 a 3 BMA O5-C1-C2 -2.21 107.36 110.774 l 3 BMA C1-C2-C3 2.20 112.37 109.676 s 4 MAN C2-C3-C4 -2.20 107.08 110.896 s 1 NAG C3-C4-C5 -2.20 106.32 110.244 e 2 NAG O4-C4-C5 2.18 114.72 109.304 Z 3 BMA C2-C3-C4 -2.17 107.14 110.895 q 5 MAN C1-C2-C3 2.16 112.32 109.674 n 3 BMA C2-C3-C4 -2.16 107.16 110.896 T 4 MAN O5-C1-C2 -2.16 107.44 110.774 j 3 BMA O5-C1-C2 -2.16 107.44 110.774 l 2 NAG C1-O5-C5 2.15 115.11 112.194 O 2 NAG O4-C4-C5 2.15 114.64 109.305 S 5 MAN C1-C2-C3 2.15 112.31 109.674 a 2 NAG O4-C4-C5 2.14 114.61 109.306 T 3 BMA C2-C3-C4 -2.14 107.19 110.895 P 2 NAG O5-C1-C2 -2.13 107.92 111.294 M 3 BMA O5-C1-C2 -2.13 107.49 110.774 e 1 NAG C3-C4-C5 -2.12 106.45 110.244 l 3 BMA O5-C1-C2 -2.12 107.50 110.774 m 1 NAG O4-C4-C3 -2.11 105.46 110.354 e 3 BMA O5-C1-C2 -2.11 107.51 110.774 O 2 NAG C1-O5-C5 2.11 115.05 112.194 J 1 NAG O4-C4-C3 -2.11 105.48 110.354 Z 2 NAG O5-C5-C4 -2.10 105.71 110.834 X 3 BMA O5-C1-C2 -2.10 107.53 110.775 d 3 BMA C2-C3-C4 -2.09 107.27 110.894 r 1 NAG C3-C4-C5 -2.09 106.51 110.245 U 4 MAN C1-C2-C3 2.08 112.23 109.674 O 2 NAG O5-C1-C2 -2.08 108.00 111.294 m 3 BMA O5-C1-C2 -2.08 107.55 110.778 f 1 NAG C4-C3-C2 -2.08 107.97 111.024 r 3 BMA O5-C1-C2 -2.08 107.56 110.77
Continued on next page...
Page 50 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(o) Ideal(o)5 q 1 NAG O4-C4-C3 -2.07 105.55 110.354 h 3 BMA C2-C3-C4 -2.07 107.32 110.895 q 4 MAN O5-C1-C2 -2.07 107.58 110.774 J 3 BMA O5-C1-C2 -2.07 107.58 110.777 p 1 NAG C3-C4-C5 -2.06 106.56 110.244 V 3 BMA O5-C1-C2 -2.05 107.60 110.774 e 2 NAG C1-O5-C5 2.05 114.97 112.194 V 2 NAG O5-C5-C4 -2.05 105.84 110.835 P 2 NAG C3-C4-C5 -2.05 106.59 110.244 X 2 NAG O5-C5-C4 -2.05 105.85 110.835 d 2 NAG O5-C5-C6 -2.04 104.00 107.204 Q 1 NAG C3-C4-C5 -2.04 106.59 110.244 Q 2 NAG C1-O5-C5 2.04 114.96 112.198 f 4 MAN O5-C1-C2 -2.04 107.62 110.776 T 2 NAG C3-C4-C5 -2.03 106.61 110.244 O 3 BMA C2-C3-C4 -2.03 107.39 110.898 f 3 BMA O5-C1-C2 -2.02 107.65 110.774 V 1 NAG O4-C4-C3 -2.02 105.68 110.355 S 3 BMA C1-O5-C5 2.01 114.92 112.195 d 5 MAN C2-C3-C4 -2.01 107.42 110.895 S 5 MAN O5-C1-C2 -2.00 107.68 110.774 Z 3 BMA O5-C1-C2 -2.00 107.68 110.77
There are no chirality outliers.
All (132) torsion outliers are listed below:
Mol Chain Res Type Atoms6 s 3 BMA C4-C5-C6-O66 s 3 BMA O5-C5-C6-O65 d 2 NAG C4-C5-C6-O64 Y 1 NAG O5-C5-C6-O67 i 2 NAG O5-C5-C6-O67 k 2 NAG C4-C5-C6-O65 U 2 NAG O5-C5-C6-O66 T 1 NAG O5-C5-C6-O66 T 2 NAG O5-C5-C6-O65 R 2 NAG C4-C5-C6-O64 J 1 NAG O5-C5-C6-O66 s 1 NAG O5-C5-C6-O67 i 2 NAG C4-C5-C6-O65 P 2 NAG C4-C5-C6-O65 R 2 NAG O5-C5-C6-O6
Continued on next page...
Page 51 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms4 c 1 NAG O5-C5-C6-O64 Y 1 NAG C4-C5-C6-O65 d 2 NAG O5-C5-C6-O65 P 2 NAG O5-C5-C6-O64 V 1 NAG O5-C5-C6-O64 K 1 NAG O5-C5-C6-O64 m 2 NAG O5-C5-C6-O64 Q 3 BMA O5-C5-C6-O64 l 2 NAG C4-C5-C6-O65 q 2 NAG C4-C5-C6-O66 T 3 BMA C4-C5-C6-O64 X 2 NAG C4-C5-C6-O68 f 2 NAG O5-C5-C6-O64 F 1 NAG O5-C5-C6-O64 N 2 NAG C4-C5-C6-O64 M 1 NAG O5-C5-C6-O64 X 1 NAG O5-C5-C6-O64 r 3 BMA O5-C5-C6-O64 c 1 NAG C4-C5-C6-O64 m 3 BMA O5-C5-C6-O65 d 4 MAN O5-C5-C6-O66 s 4 MAN O5-C5-C6-O66 s 1 NAG C4-C5-C6-O66 T 1 NAG C4-C5-C6-O64 F 1 NAG C4-C5-C6-O64 M 1 NAG C4-C5-C6-O65 q 2 NAG O5-C5-C6-O64 X 1 NAG C4-C5-C6-O68 f 2 NAG C4-C5-C6-O65 U 4 MAN O5-C5-C6-O65 S 5 MAN O5-C5-C6-O68 f 4 MAN O5-C5-C6-O64 n 3 BMA O5-C5-C6-O64 M 3 BMA O5-C5-C6-O64 c 3 BMA O5-C5-C6-O64 a 1 NAG O5-C5-C6-O64 e 3 BMA O5-C5-C6-O65 R 5 MAN O5-C5-C6-O64 j 3 BMA O5-C5-C6-O64 N 1 NAG O5-C5-C6-O64 K 1 NAG C4-C5-C6-O64 Y 3 BMA O5-C5-C6-O6
Continued on next page...
Page 52 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms4 N 3 BMA O5-C5-C6-O64 F 3 BMA O5-C5-C6-O65 U 2 NAG C4-C5-C6-O66 T 4 MAN O5-C5-C6-O65 R 1 NAG O5-C5-C6-O65 S 4 MAN O5-C5-C6-O64 h 3 BMA O5-C5-C6-O64 J 3 BMA O5-C5-C6-O64 X 3 BMA O5-C5-C6-O64 t 3 BMA O5-C5-C6-O64 a 3 BMA O5-C5-C6-O64 V 3 BMA O5-C5-C6-O64 K 3 BMA O5-C5-C6-O64 Z 3 BMA O5-C5-C6-O65 U 5 MAN O5-C5-C6-O68 g 4 MAN O5-C5-C6-O64 m 2 NAG C4-C5-C6-O66 T 2 NAG C4-C5-C6-O67 b 2 NAG C4-C5-C6-O67 k 2 NAG O5-C5-C6-O65 U 3 BMA C4-C5-C6-O65 P 3 BMA C4-C5-C6-O65 R 4 MAN O5-C5-C6-O67 o 1 NAG O5-C5-C6-O68 f 3 BMA C4-C5-C6-O65 P 4 MAN O5-C5-C6-O65 d 5 MAN O5-C5-C6-O65 q 4 MAN O5-C5-C6-O67 p 1 NAG O5-C5-C6-O65 S 3 BMA C4-C5-C6-O68 g 3 BMA C4-C5-C6-O64 O 3 BMA O5-C5-C6-O64 V 1 NAG C4-C5-C6-O65 P 5 MAN O5-C5-C6-O65 q 5 MAN O5-C5-C6-O65 R 3 BMA C4-C5-C6-O64 e 2 NAG O5-C5-C6-O66 T 3 BMA O5-C5-C6-O64 Q 1 NAG O5-C5-C6-O64 J 1 NAG C4-C5-C6-O65 d 3 BMA C4-C5-C6-O67 k 1 NAG O5-C5-C6-O6
Continued on next page...
Page 53 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms4 M 2 NAG C4-C5-C6-O64 X 2 NAG O5-C5-C6-O64 l 3 BMA O5-C5-C6-O65 S 2 NAG O5-C5-C6-O65 R 1 NAG C4-C5-C6-O64 h 1 NAG O5-C5-C6-O64 l 1 NAG O5-C5-C6-O64 j 1 NAG O5-C5-C6-O64 N 1 NAG C4-C5-C6-O64 a 1 NAG C4-C5-C6-O64 N 2 NAG O5-C5-C6-O64 l 2 NAG O5-C5-C6-O65 q 3 BMA C4-C5-C6-O64 O 2 NAG O5-C5-C6-O65 U 3 BMA O5-C5-C6-O65 P 3 BMA O5-C5-C6-O64 c 2 NAG O5-C5-C6-O65 R 3 BMA O5-C5-C6-O64 t 1 NAG O5-C5-C6-O64 Q 3 BMA C4-C5-C6-O68 f 3 BMA O5-C5-C6-O68 g 3 BMA O5-C5-C6-O65 q 1 NAG O5-C5-C6-O65 d 3 BMA O5-C5-C6-O67 o 2 NAG C4-C5-C6-O67 b 2 NAG O5-C5-C6-O65 S 3 BMA O5-C5-C6-O64 e 2 NAG C4-C5-C6-O64 Z 1 NAG O5-C5-C6-O64 M 1 NAG C1-C2-N2-C77 o 1 NAG C4-C5-C6-O66 s 4 MAN C4-C5-C6-O67 p 1 NAG C4-C5-C6-O6
There are no ring outliers.
No monomer is involved in short contacts.
The following is a two-dimensional graphical depiction of Mogul quality analysis of bond lengths,bond angles, torsion angles, and ring geometry for oligosaccharide.
Page 54 Full wwPDB EM Validation Report EMD-0404, 6NB7
Oligosaccharide Chain J
Bond lengths Bond angles
Torsions Rings
Oligosaccharide Chain K
Bond lengths Bond angles
Torsions Rings
Page 55 Full wwPDB EM Validation Report EMD-0404, 6NB7
Oligosaccharide Chain M
Bond lengths Bond angles
Torsions Rings
Oligosaccharide Chain N
Bond lengths Bond angles
Torsions Rings
Page 56 Full wwPDB EM Validation Report EMD-0404, 6NB7
Oligosaccharide Chain O
Bond lengths Bond angles
Torsions Rings
Oligosaccharide Chain Q
Bond lengths Bond angles
Torsions Rings
Page 57 Full wwPDB EM Validation Report EMD-0404, 6NB7
Oligosaccharide Chain V
Bond lengths Bond angles
Torsions Rings
Oligosaccharide Chain X
Bond lengths Bond angles
Torsions Rings
Page 58 Full wwPDB EM Validation Report EMD-0404, 6NB7
Oligosaccharide Chain Y
Bond lengths Bond angles
Torsions Rings
Oligosaccharide Chain Z
Bond lengths Bond angles
Torsions Rings
Page 59 Full wwPDB EM Validation Report EMD-0404, 6NB7
Oligosaccharide Chain P
Bond lengths Bond angles
Torsions Rings
Page 60 Full wwPDB EM Validation Report EMD-0404, 6NB7
Oligosaccharide Chain R
Bond lengths Bond angles
Torsions Rings
Page 61 Full wwPDB EM Validation Report EMD-0404, 6NB7
Oligosaccharide Chain S
Bond lengths Bond angles
Torsions Rings
Page 62 Full wwPDB EM Validation Report EMD-0404, 6NB7
Oligosaccharide Chain U
Bond lengths Bond angles
Torsions Rings
Oligosaccharide Chain T
Bond lengths Bond angles
Torsions Rings
Page 63 Full wwPDB EM Validation Report EMD-0404, 6NB7
Oligosaccharide Chain W
Bond lengths Bond angles
Torsions Rings
5.6 Ligand geometry i○
16 ligands are modelled in this entry.
In the following table, the Counts columns list the number of bonds (or angles) for which Mogulstatistics could be retrieved, the number of bonds (or angles) that are observed in the model andthe number of bonds (or angles) that are defined in the Chemical Component Dictionary. TheLink column lists molecule types, if any, to which the group is linked. The Z score for a bondlength (or angle) is the number of standard deviations the observed value is removed from theexpected value. A bond length (or angle) with |Z| > 2 is considered an outlier worth inspection.RMSZ is the root-mean-square of all Z scores of the bond lengths (or angles).
Mol Type Chain Res Link Bond lengths Bond anglesCounts RMSZ #|Z| > 2 Counts RMSZ #|Z| > 2
9 NAG B 1320 1 14,14,15 2.21 3 (21%) 17,19,21 0.80 1 (5%)9 NAG C 1302 1 14,14,15 2.15 4 (28%) 17,19,21 0.98 1 (5%)9 NAG A 1311 1 14,14,15 2.20 2 (14%) 17,19,21 0.92 1 (5%)
Page 64 Full wwPDB EM Validation Report EMD-0404, 6NB7
Mol Type Chain Res Link Bond lengths Bond anglesCounts RMSZ #|Z| > 2 Counts RMSZ #|Z| > 2
9 NAG B 1302 1 14,14,15 2.16 2 (14%) 17,19,21 0.77 1 (5%)9 NAG A 1303 1 14,14,15 2.18 2 (14%) 17,19,21 0.92 1 (5%)9 NAG A 1310 1 14,14,15 2.15 2 (14%) 17,19,21 0.77 09 NAG B 1301 1 14,14,15 2.05 2 (14%) 17,19,21 1.27 2 (11%)9 NAG C 1303 1 14,14,15 1.82 3 (21%) 17,19,21 0.91 09 NAG B 1303 1 14,14,15 2.15 1 (7%) 17,19,21 0.74 09 NAG A 1321 1 14,14,15 2.19 1 (7%) 17,19,21 0.75 09 NAG B 1309 1 14,14,15 2.19 3 (21%) 17,19,21 0.90 1 (5%)9 NAG C 1301 1 14,14,15 2.28 2 (14%) 17,19,21 1.29 1 (5%)9 NAG A 1302 1 14,14,15 2.10 1 (7%) 17,19,21 0.74 09 NAG B 1310 1 14,14,15 2.18 1 (7%) 17,19,21 0.79 1 (5%)9 NAG A 1301 1 14,14,15 2.14 2 (14%) 17,19,21 1.10 1 (5%)9 NAG C 1320 1 14,14,15 2.18 2 (14%) 17,19,21 0.97 1 (5%)
In the following table, the Chirals column lists the number of chiral outliers, the number of chiralcenters analysed, the number of these observed in the model and the number defined in theChemical Component Dictionary. Similar counts are reported in the Torsion and Rings columns.’-’ means no outliers of that kind were identified.
Mol Type Chain Res Link Chirals Torsions Rings9 NAG B 1320 1 - 1/6/23/26 0/1/1/19 NAG C 1302 1 - 1/6/23/26 0/1/1/19 NAG A 1311 1 - 1/6/23/26 0/1/1/19 NAG B 1302 1 - 1/6/23/26 0/1/1/19 NAG A 1303 1 - 1/6/23/26 0/1/1/19 NAG A 1310 1 - 1/6/23/26 0/1/1/19 NAG B 1301 1 - 1/6/23/26 0/1/1/19 NAG C 1303 1 - 1/6/23/26 0/1/1/19 NAG B 1303 1 - 1/6/23/26 0/1/1/19 NAG A 1321 1 - 2/6/23/26 0/1/1/19 NAG B 1309 1 - 2/6/23/26 0/1/1/19 NAG C 1301 1 - 1/6/23/26 0/1/1/19 NAG A 1302 1 - 1/6/23/26 0/1/1/19 NAG B 1310 1 - 1/6/23/26 0/1/1/19 NAG A 1301 1 - 2/6/23/26 0/1/1/19 NAG C 1320 1 - 2/6/23/26 0/1/1/1
All (33) bond length outliers are listed below:
Page 65 Full wwPDB EM Validation Report EMD-0404, 6NB7
Mol Chain Res Type Atoms Z Observed(Å) Ideal(Å)9 C 1301 NAG O5-C1 7.52 1.55 1.439 A 1321 NAG O5-C1 7.19 1.55 1.439 B 1310 NAG O5-C1 7.19 1.55 1.439 A 1303 NAG O5-C1 7.15 1.55 1.439 B 1320 NAG O5-C1 7.15 1.55 1.439 B 1309 NAG O5-C1 7.12 1.55 1.439 A 1311 NAG O5-C1 7.11 1.55 1.439 B 1302 NAG O5-C1 7.09 1.55 1.439 C 1320 NAG O5-C1 7.07 1.55 1.439 A 1310 NAG O5-C1 7.00 1.54 1.439 B 1303 NAG O5-C1 6.99 1.54 1.439 C 1302 NAG O5-C1 6.88 1.54 1.439 A 1301 NAG O5-C1 6.88 1.54 1.439 A 1302 NAG O5-C1 6.80 1.54 1.439 B 1301 NAG O5-C1 6.57 1.54 1.439 C 1303 NAG O5-C1 5.09 1.51 1.439 C 1303 NAG C4-C3 2.67 1.59 1.529 C 1302 NAG C4-C3 2.33 1.58 1.529 C 1302 NAG C3-C2 -2.32 1.47 1.529 C 1302 NAG C4-C5 2.26 1.57 1.539 C 1301 NAG O3-C3 2.22 1.48 1.439 A 1311 NAG C3-C2 -2.18 1.47 1.529 A 1301 NAG C3-C2 -2.18 1.47 1.529 B 1309 NAG C3-C2 -2.13 1.48 1.529 B 1301 NAG C3-C2 -2.12 1.48 1.529 A 1310 NAG C3-C2 -2.06 1.48 1.529 A 1303 NAG C3-C2 -2.04 1.48 1.529 B 1320 NAG C4-C3 2.04 1.57 1.529 B 1302 NAG C4-C3 2.04 1.57 1.529 B 1309 NAG C4-C3 2.03 1.57 1.529 B 1320 NAG C3-C2 -2.02 1.48 1.529 C 1303 NAG C3-C2 -2.02 1.48 1.529 C 1320 NAG C4-C3 2.01 1.57 1.52
All (12) bond angle outliers are listed below:
Mol Chain Res Type Atoms Z Observed(o) Ideal(o)9 A 1301 NAG C4-C3-C2 -3.26 106.24 111.029 C 1301 NAG C4-C3-C2 -3.23 106.28 111.029 C 1302 NAG C4-C3-C2 -3.20 106.33 111.029 C 1320 NAG C4-C3-C2 -2.94 106.71 111.029 B 1301 NAG C4-C3-C2 -2.79 106.93 111.029 A 1311 NAG C4-C3-C2 -2.68 107.09 111.02
Continued on next page...
Page 66 Full wwPDB EM Validation Report EMD-0404, 6NB7
Continued from previous page...Mol Chain Res Type Atoms Z Observed(o) Ideal(o)9 A 1303 NAG C4-C3-C2 -2.50 107.35 111.029 B 1309 NAG C4-C3-C2 -2.48 107.38 111.029 B 1320 NAG C4-C3-C2 -2.15 107.86 111.029 B 1310 NAG C4-C3-C2 -2.03 108.04 111.029 B 1302 NAG C4-C3-C2 -2.00 108.08 111.029 B 1301 NAG C1-O5-C5 -2.00 109.48 112.19
There are no chirality outliers.
All (20) torsion outliers are listed below:
Mol Chain Res Type Atoms9 A 1301 NAG O5-C5-C6-O69 A 1321 NAG O5-C5-C6-O69 C 1320 NAG O5-C5-C6-O69 A 1310 NAG O5-C5-C6-O69 B 1310 NAG O5-C5-C6-O69 B 1302 NAG O5-C5-C6-O69 B 1320 NAG O5-C5-C6-O69 A 1302 NAG O5-C5-C6-O69 A 1311 NAG O5-C5-C6-O69 A 1303 NAG O5-C5-C6-O69 C 1301 NAG O5-C5-C6-O69 B 1303 NAG O5-C5-C6-O69 A 1301 NAG C4-C5-C6-O69 C 1302 NAG O5-C5-C6-O69 C 1303 NAG O5-C5-C6-O69 B 1301 NAG O5-C5-C6-O69 B 1309 NAG O5-C5-C6-O69 A 1321 NAG C4-C5-C6-O69 C 1320 NAG C4-C5-C6-O69 B 1309 NAG C4-C5-C6-O6
There are no ring outliers.
No monomer is involved in short contacts.
5.7 Other polymers i○
There are no such residues in this entry.
Page 67 Full wwPDB EM Validation Report EMD-0404, 6NB7
5.8 Polymer linkage issues i○
There are no chain breaks in this entry.
Page 68 Full wwPDB EM Validation Report EMD-0404, 6NB7
6 Map visualisation i○
This section contains visualisations of the EMDB entry EMD-0404. These allow visual inspectionof the internal detail of the map and identification of artifacts.
No raw map or half-maps were deposited for this entry and therefore no images, graphs, etc.pertaining to the raw map can be shown.
6.1 Orthogonal projections i○
6.1.1 Primary map
X Y Z
The images above show the map projected in three orthogonal directions.
6.2 Central slices i○
6.2.1 Primary map
X Index: 150 Y Index: 150 Z Index: 150
Page 69 Full wwPDB EM Validation Report EMD-0404, 6NB7
The images above show central slices of the map in three orthogonal directions.
6.3 Largest variance slices i○
6.3.1 Primary map
X Index: 154 Y Index: 158 Z Index: 154
The images above show the largest variance slices of the map in three orthogonal directions.
6.4 Orthogonal surface views i○
6.4.1 Primary map
X Y Z
The images above show the 3D surface view of the map at the recommended contour level 1.2.These images, in conjunction with the slice images, may facilitate assessment of whether an ap-propriate contour level has been provided.
Page 70 Full wwPDB EM Validation Report EMD-0404, 6NB7
6.5 Mask visualisation i○
This section was not generated. No masks/segmentation were deposited.
Page 71 Full wwPDB EM Validation Report EMD-0404, 6NB7
7 Map analysis i○
This section contains the results of statistical analysis of the map.
7.1 Map-value distribution i○
The map-value distribution is plotted in 128 intervals along the x-axis. The y-axis is logarithmic.A spike in this graph at zero usually indicates that the volume has been masked.
Page 72 Full wwPDB EM Validation Report EMD-0404, 6NB7
7.2 Volume estimate i○
The volume at the recommended contour level is 452 nm3; this corresponds to an approximatemass of 408 kDa.
The volume estimate graph shows how the enclosed volume varies with the contour level. Therecommended contour level is shown as a vertical line and the intersection between the line andthe curve gives the volume of the enclosed surface at the given level.
Page 73 Full wwPDB EM Validation Report EMD-0404, 6NB7
7.3 Rotationally averaged power spectrum i○
*Reported resolution corresponds to spatial frequency of 0.222 Å−1
Page 74 Full wwPDB EM Validation Report EMD-0404, 6NB7
8 Fourier-Shell correlation i○
This section was not generated. No FSC curve or half-maps provided.
Page 75 Full wwPDB EM Validation Report EMD-0404, 6NB7
9 Map-model fit i○
This section contains information regarding the fit between EMDB map EMD-0404 and PDBmodel 6NB7. Per-residue inclusion information can be found in section 3 on page 17.
9.1 Map-model overlay i○
X Y Z
The images above show the 3D surface view of the map at the recommended contour level 1.2 at50% transparency in yellow overlaid with a ribbon representation of the model coloured in blue.These images allow for the visual assessment of the quality of fit between the atomic model andthe map.
Page 76 Full wwPDB EM Validation Report EMD-0404, 6NB7
9.2 Atom inclusion i○
At the recommended contour level, 91% of all backbone atoms, 85% of all non-hydrogen atoms,are inside the map.